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Mammalian histogenesis is a sophisticated process of coordinated changes of cellular 
composition governed by selective gene expression. This thesis focuses on the systematic 
application of modern RNA-seq methods to histogenesis processes in developing mouse 
embryos. Most of the work presented here is conducted as part of the ENCODE 
(ENCyclopedia Of DNA Elements) Project. Chapter 1 introduces the current advances of 
transcriptome studies on tissue development. Chapter 2 discusses a large-scale study on 
the whole-tissue transcriptome of 12 embryonic tissues at up to 8 timepoints and 5 
additional perinatal tissues. Coherent themes of biological function and underlying 
regulatory mechanisms are revealed from the large-scale analysis. Chapter 3 presents a 
high-resolution single-cell RNA-seq study focused on the developing forelimb of the 
mouse embryo. This approach enables the assignment of differential genes to 
corresponding lineages and provides an even more accurate picture of RNA level patterns 
and regulatory modes. Finally, whole-tissue and single-cell methods are compared, 
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C h a p t e r  1  
CURRENT ADVANCES IN TRANSCRIPTOME STUDIES 
Abstract 
In the past decade, second-generation sequencing has spurred a wave of more 
comprehensive and quantitative transcriptome assays. New technologies enabled accurate 
transcript counting with new isoform discovery, pushed sensitivity limitation towards 
single-cell standard, increased throughput to up to tens of thousands of cells per 
experiment, and are moving towards in situ measurement with comparable sensitivity and 
resolution. In this chapter, I am going to introduce the current advances in the field of 
transcriptomics with a focus on the application on development.  
1.1 Introduction 
The mammalian genome is estimated to contain more than 40,000 genes, responsible for 
the full variety of structures and functions in every cell of a tissue throughout the life of 
the animal. Each cell selectively expresses a subset of genes that defines its identity and 
function. To read out gene expression profiles, polyadenylated RNAs have been widely 
used as indicators of genome output. Thanks to their well-defined and coherent 
biochemical property, massive parallel quantification had been achieved as early as 1995 
using microarray probe hybridization1. Although this method provided easy measurement 
for known transcripts, it was bounded by prior knowledge, could not discover novel 
sequences, and had trouble detecting splice isoforms and other more subtle sequence 




Sequencing-based methods have been independently developed to characterize 
transcripts without prior knowledge2,3,4. A breakthrough was achieved that was especially 
important for the complex transcriptomes of large mammalian genomes5,6. RNA-seq, 
which is based on sequencing cDNA, provided the ability to discover new transcripts, 
and higher sensitivity to detect rare but meaningful transcripts from low amounts of input 
material. This triggered a revolution in transcriptome quantification7 and helped prompt 
the trend to convert “omics” and screening studies into a count-by-sequencing problem8 
that could be routinely solved across virtually all organisms. 
The technology boundary was further pushed to achieve single-cell resolution. This 
required optimizations in library construction9,10 and manipulation of microfluidics11,12,13 
to enable increasingly large-scale single-cell readout. High-throughput single-cell 
measurements provide the power to deconvolute tissue complexity. A subset of these 
methods can also take on more demanding questions about the differences among similar 




been carried out to understand tissue development at whole-tissue14,15,16,17 and single-
cell levels18,19,20,21,22,23,24.  
I am going to briefly introduce the development and most pertinent characteristics of 
current transcriptome methods and their application to tissue development, the subject of 
this thesis. 
1.2 The molecular biology and bioinformatics of mRNA quantification 
mRNA is a good proxy for gene expression due to the ease to transfer its sequence 
information into double-stranded DNAs for second-generation sequencing and its 
reasonable correlation with protein-abundance25. However, the majority of intracellular 
RNAs are ribosomal RNAs (rRNAs) that do not serve as templates for translation. To 
enrich signals, microarray-based methods cherry-picked known transcripts one by one 
through probe hybridization. Sequencing-based methods mainly use two different types 
of strategies to focus the sequencing resources on the RNAs of interest (typically aiming 
for mature mRNAs and lncRNAs). The first strategy is to remove ribosomal RNAs by 
probe hybridization before downstream library construction26. This method (variously 
called total RNA-seq26 or Ribo-minus RNA-seq27) not only captures mature mRNAs but 
also other non-polyA RNAs such as histone mRNAs and immature RNAs28. Meanwhile, 
short RNAs such as snoRNAs, miRNAs, and tRNAs can also remain and still consume 
the majority of the reads. A pre-selection based on the sizes of intact total RNAs29 is 
usually required before library construction to combat this problem. The relative success 
of these biochemical enrichments varies with protocol details and execution and is not 




extra technical factors that influence variation and subsequent quantifications. The 
second approach is to positively select polyA RNA either by Oligo(dT) selection5 or 
Oligo(dT) priming30. This method focuses on polyA RNA only and has been the more 
widely used choice for mRNA sequencing. In the following part of this chapter, the word 
“RNA-seq” will only refer to the latter strategy. 
RNA-seq makes use of second-generation sequencing methods to dilute cDNA libraries 
and count the sequencing reads derived that match the sequences of each gene. Unlike 
DNA mapping, RNAs may contain splice sites so that a read can “jump” over intron 
regions, adding to the difficulty of quantification. Methods that can map junction-
spanning reads31,32 and those that compare mapped coordinates with transcript 
annotations33,34 have been developed and improved35,36,37. More recently, alignment-free 
methods directly look for reads that can match known transcript sequences without 
mapping to the whole genome and guessing how transcripts are spliced38,39. This recent 
kind of fast methods essentially works as “artificial microarrays” as they only look for 
counts of known transcripts, except that their “probes” have much lower cross-
hybridization confusion than to the microarray’s physical probes. On the other hand, for 
unknown transcript and isoform discovery, RNA-seq data can be fruitfully used to detect 
and reconstruct novel transcript structures to add to existing annotations for 
quantification of new isoforms40,41,42. 
Contemporary RNA-seq is a stochastic sampling process that does not give absolute copy 




calibration43. Normalization is required to correct for different sequencing depth when 
comparing between samples and to correct for transcript lengths when comparing 
between transcripts. Therefore, read counts are usually divided by sequencing depth and 
transcript length and adjusted in orders of magnitude to yield RPKM (reads per kilobase 
of exon model per million mapped reads) or FPKM (fragments per kilobase of transcript 
per million mapped reads) values5. However, in the past years, other metrics were 
proposed such as RPM (reads per million mapped reads) /CPM (counts per million) 44 
and TPM (transcripts per million) 45 aimed at using units that can sum to a constant 
within every sample to try to achieve more faithful estimation of real physical 
parameters, which may not be as good as they claimed.  
It has been a long journey to figure out what the most physiologically meaningful metric 
is for RNA. RT-qPCR methods used putative “house-keeping” genes as controls to get 
relative abundance46,47. However, as I learn more and survey a wider range of cell types 
and cell states, the notion of a very stable and reliable RNA level per cell has broken 
down. To my knowledge now, there is no house-keeping gene or gene set whose 
transcript abundance may be constant48, and this is even more true at single-cell level. 
This means that historic studies need to be viewed with the knowledge that the amount of 
a housekeeping standard transcript is really a sampled distribution that is probably quite 
good for comparing multiple samples of a given tissue or cell type, but nevertheless is 
likely to have systematic issues across different tissues, cell types, and genotypes. Unlike 
qPCR, RNA-seq normalizes its signal against a whole-cell sum that is likely to be more 




the mass of each transcript among different transcripts in the same sample, while 
FPKM and TPM consider transcript length and therefore are both proportional to the 
molar concentration and copy number of each transcript among different transcripts in 
the same sample. On the other hand, when comparing the same transcript among 
different samples, which is what RNA-seq is mostly aimed to do, CPM and FPKM for 
the same transcript would go hand-in-hand (if CPM of a transcript in Sample A is higher 
than that in Sample B, FPKM in A would also be higher than that of Sample B), both 
reflecting relative mass of that transcript, while TPM measures relative molar 
concentration. Therefore, comparing these units across samples depends on how a 
biologist defines the “fraction” (of mass or counts). It is not yet sure what is a more 
meaningful parameter for gene expression measurement as a predictor of protein output, 
since the mass (and thus length) of each transcript may be related to how much 
translational machinery it can take if longer transcripts can bind and use more ribosomes. 
But we also know that rates of ribosome loading and translational pauses (or lack thereof) 
vary for certain messages and entire systems, meaning that there are exceptions to overall 
length/loading generalization. On the other hand, relative molar concentration would be a 
better estimator if we believe all the transcripts share more or less the same translation 
rate per copy. We cannot know for sure which proposal is the ideal normalization method 




interpret “concentration”. One experimental effort to better estimate gene expression 
using transcriptomic approach is to profile ribosomes on transcripts49. 
Another important task for RNA quantification, and the most central one presently in the 
areas of developmental biology, is differential RNA level analysis. To compare gene 
expressions between two samples, multiple computational methods have been developed, 
and negative binomial model-based algorithms proved to be able to capture read-count 
over dispersion compared to Poisson models50,51. However, due to the fact that 
biologically meaningful RNA levels often differ by orders of magnitudes and that their 
estimated abundance follows log-normal distribution, it has also become a common 
practice in the wider community to use t-test and ANOVA on log-transformed FPKM or 
TPM values.  
 Log-transformed FPKM values have also been frequently used when multiple samples 
get compared and grouped. Principal component analysis52 (PCA) has been widely used 
to find “components” of co-expressed modules, classify samples, and reduce 
dimensionality to understand the main features of the data collection. Similarly used 
methods also include clustering analyses53,54,55 and numerous other methods56,57,58,59 for 
data mining among large-scale datasets. A more recent method60,61 has been combining 
PCA and CCA (canonical correlation analysis)62 to explain data structures based on 





Applying RNA-seq quantification approaches to multiple samples have already showed 
off its power to quantitatively and comprehensively define the development of individual 
tissues. By comparing different tissues at different developmental stages, tissue-specific, 
age-dependent, and ubiquitous gene expression patterns have been revealed17,63,64,65,66,67. 
These studies formed some initial pictures of the structure of mouse transcriptome. 
Pervouchine et al. discovered that up to 40% of evolutionarily conserved genes are 
relatively constant across cell types in the mouse genome17. Lin et al.66 did a joint RNA-
seq analysis of human and mouse tissues and discovered that gene expression profiles are 
more dominated by tissue type instead of organism identity. Among these dominant 
tissue-specific signatures, those of testes, brain, liver, muscle, and kidney were the most 
prominent in terms of the number of tissue-specific genes. A similar conclusion was 
derived by Söllner et al.68 independently. Additionally, in the latter study, thymus and 
pancreas turned out to be the top two outliers separated from other tissues and their PCA 
plot showed that the brain and liver mark the two extremes of the top principle 
component among mouse tissues in their collection. These discoveries show that the 
hierarchical mouse transcriptome contains dominant structures that can be reproducibly 
identified, as well as minor features that may be under-emphasized in different degrees 
due to different experimental and computational setup.  
However, there has not been a large-scale systematic study of multiple samples spanning 
multiple time points assayed in the same way in embryonic mice to gain insights on gene 
regulation. To achieve this, on one hand, a larger-scale study at high depth elevates 




other hand, emerging single-cell technology brings new possibilities to mine more 
deeply into the complexity of a given tissue development. 
1.3 Single-cell resolution 
Measuring the single-cell transcriptome has long been a goal for developmental 
biologists69,70. Improvement in RNA-seq library construction made it possible to measure 
a large number of transcripts in the same cell with reasonable sensitivity9,10. It was 
discovered that gene expression variations among single cells is largely attributed to 
intrinsic biological variations rather than merely technical stochasticity71. Integration of 
mRNA-seq library construction with FACS sorting72, microfluidics11,13,12, pool-split 
barcoding73, and microwell handling74,75 further increased the throughput of single-cell 
RNA-seq assays. These methods come in two major categories: full-length profiling or 3’ 
tagging76. Full-length profiling methods such as MARS-seq72 and C1 Fluidigm SMART-
seq assays11 provide good coverage over longer transcripts and thus have higher isoform 
resolution. Gene expression levels are usually measured in FPKM or TPM units. 3’ 
tagging methods such as inDrop13, Drop-seq12, Seq-well74, and Microwell-Seq75 use 3’ 
terminal sequence of transcripts as an anchor point for mRNA capture and gene 
identification. Although this method cannot resolve splice isoforms, it is easy to perform 
on beads that can greatly scale up parallel reactions and increase sample size at the 
sacrifice of per-cell quality. This class of methods usually quantifies RNA in digital 
counts. 
Unlike traditional “whole-tissue” RNA-seq methods, single-cell RNA-seq meets the 




of the sources of noise in classical RNA-seq comes from differential PCR 
amplification when multiple PCR cycles are involved, which are part of the standard 
methods. To solve this problem, two major approaches have been developed. One way is 
to trace the original cDNA fragment by introducing a short random polymer DNA tag 
called unique molecular identifier (UMI)77 during reverse transcription. This method 
keeps an ID of each individual starter cDNA fragment and helps collapsing PCR 
duplicates that have the same tag. UMI-based methods have been a routine and generally 
effective part of droplet-based 3’ tagging methods except for occasional PCR-based 
errors that can produce nucleotide substitution and indels in the UMIs78. Another 
approach is to eliminate PCR-based exponential amplification steps. One such example is 
CEL-seq79,80, which linearly amplifies cDNA sequences to minimize over-amplification 
noise and has demonstrated its power to build a cell atlas for early Caenorhabditis 
elegans embryo development. 
As single-cell RNA-seq is gradually improved and democratized, development biology 
has been experiencing more cell type-level discoveries. So far, single-cell RNA-seq has 
been used most to discover novel cell types23,24, compare and contrast cell 
compositions75,81, and increasingly, to track cell lineage during migration82, 
differentiation83, and regeneration19 in embryos and tissues.  
The ability to infer cell lineage maps based on large numbers of single-cell snapshots of 
gene expression is especially intriguing for development biologists. Taking advantage of 




sampling experiment usually captures cells at “intermediate” states in a lineage, 
multiple computational approaches have been developed to infer lineage relationships 
between cells based on their pair-wise similarity. A first group of methods such as 
Monocle85,86 and Waterfall87 reduces transcriptome dimensionality and then constructs a 
minimum spanning tree to define the backbone of the trajectory tree before filling in 
details with individual cells. A second group of methods such as Wanderlust88 and 
Wishbone89 uses k-nearest neighbor (knn) graphs to link similar cells together and then 
smoothen out a shortest path with or without bifurcation allowed. Unlike these methods, 
a more recent algorithm goes on a different path. This algorithm called RNA velocity90 
implements the idea that unspliced pre-mRNAs foreshadow cell fate transition91 utilizing 
the fact that these pre-mRNA sequences are present in the single-cell RNA-seq10 due to 
mis-priming. Therefore, based on these hitchhiked pre-mRNAs, RNA velocity algorithm 
constructs a hypothetical “extrapolated state” linked to each of the single cells. It not only 
predicts the direction a cell is moving in but also estimates how fast the transition will be. 
It would be interesting to compare these lineage inference algorithms among themselves 
and against experimental lineage tracing methods92,93 for evaluation. 
In terms of its application to embryo development, single-cell RNA-seq has so far been 
used to construct large-scale cell-type maps in multiple tissues by at least two 
independent teams81,75. Both of them were able to find distinct cell types, common or 
biased, between different organs. Single-cell RNA-seq has also been coupled with a 
lineage-tracing method to construct a lineage map of the zebrafish embryo83. 




on cell states is not necessarily overlapping with the real lineage history83, which raises 
the question about what a “lineage map” really means. The power of single-cell RNA-seq 
to define cell types has also been used to infer regulatory codes. Buenrostro et al.94 
integrated single-cell RNA-seq and single-cell ATAC-seq of the same sample and were 
able to match their subpopulations. By matching gene expression profiles with chromatin 
accessibility, they were able to infer transcription factors that potentially regulate cell 
state maintenance and transition. As more and more single-cell characterization studies 
are done, the structure of cell type-specific gene expression and regulation would become 
increasingly clear. 
1.4 New directions 
Transcriptome studies have evolved rapidly in the past decade, from whole-tissue to 
single-cell and from low-throughput to high-throughput. Their evolution is still going on. 
Tissue development is a coordinated process where cells interact with each other in a 
limited space with carefully tuned distribution of chemical cues and mechanical 
parameters. Spatial information that RNA-seq can acquire is usually limited by the 
minimal dissection size of a tissue. Although laser-assisted microdissection techniques 
may accurately extract samples or cells at a defined spatial coordinate on a tissue95,96, 
they cannot be done in both a precise and high-throughput way. Therefore, multiple 
teams have been developing high-throughput versions of single-cell RNA-seq that 
maintain spatial information. One established method is called “spatial transcriptomics” 
that aligns an array of barcoded reverse transcription primers against histological sections 




library construction97. This method achieves a resolution at 100um (10-20 cells) but 
can be further deconvoluted by single-cell RNA-seq from a comparable sample98. New 
ways of introducing spatial barcodes before downstream RNA sequencing may give rise 
to better spatial transcriptomic methods. Recent prototypes of “probe hybridization”-
based methods such as seqFISH99 and MERFISH100 show that spatial patterns of up to 
1000 RNA species can be visualized with single-cell resolution. Intron seqFISH further 
demonstrated its polyA-independent advantage by labeling more than 10,000 nascent 
transcripts to study transcription dynamics101. Another hybridization-based method was 
recently introduced as “STARmap”, which used in situ sequencing to amplify signals and 
claimed to be able to read out spatial transcriptome of 3D intact tissues102. These imaging 
methods may hold great promise for single-cell spatial transcriptomics and may be 
integrated with tissue clearing103,104, super resolution microscopy105,106 and expansion 
microscopy107 for additional benefits. However, the methods mentioned above all depend 
on careful experimental setup, such as the choice of probes to label specific marker 
genes. Further efforts are still needed to transparentize, simplify, and standardize detailed 
protocols of existing methods for broader applications.  
Although spatial transcriptome can be probed by hybridization, complex isoform 
specificity is hardly achieved, nor can short-read RNA-seq. But development of long-
read sequencing methods such as nanopore108 and PacBio109 makes it possible to quantify 
transcripts with clear isoform specificity combined with full-length RNA-seq and single-
cell RNA-seq methods. Long-read methods may also reveal allelic information when 




Transcriptomic measurements can also be integrated with other assays in the same cell 
to bona fide link transcription to other aspects of cellular physiology. Efforts are been 
made for single-cell RNA-seq to incorporate information of genomic DNA110,111,112,113, 
chromatin accessibility114, protein abundance115,116,117,118, perturbation119,120,121,122,83, and 
DNA methylation123. More multi-omics single-cell approaches will be or are already 
being developed. 
With existing technology getting stabilized and new approaches emerging, large-scale 
transcriptome data integration and cell type taxonomy construction were made possible. 
Projects like the Human Cell Atlas124 have thus been initiated, benefiting from existing 
technology and in turn spurring new technology. Through collaborative efforts and 







C h a p t e r  2  
GLOBAL ANALYSIS OF WHOLE-TISSUE MOUSE EMBRYOGENESIS 
TIMECOURSE 
Abstract 
Mammalian development is driven by selective gene expression and cell population 
coordination. To understand the dynamic modules of the gene regulatory network 
governing histogenesis during embryo development, I present here a collection of 
embryonic mouse transcriptome using the whole-tissue RNA sequencing method (RNA-
seq). Transcript diversity and dynamics were explored in 12 tissues from E10.5 to birth. 
Five additional tissues at P0 were added to facilitate comparative analysis. Overall, 
among the 24,832 genes expressed, 63% were strongly differential, revealing strong 
temporal and tissue-specific components with underlying cell-proliferation, characteristic 
function, specialized function, and body-axis signatures. These differential genes formed 
34 major co-expression clusters with known or novel functions and putative promoter 
regulatory codes. Interestingly, the remaining ubiquitous genes were associated with 
potential post-transcriptional regulations in addition to their promoter signature. This 
study not only presents a broad view of mouse embryonic development as part of the 
ENCODE project but also provides a processed data framework for users to integrate 
their own input. 
2.1 Introduction 
Hierarchical transcription programs unfold to regulate mammalian development through 




transcriptome with reasonable sensitivity, existing studies126,17,127 were done only for 
selected cell lineages and subsets of tissues in the developing mouse with minimal 
temporal resolution. Efforts to assemble multiple sources of data and analyze a broad 
developmental atlas is precluded by different methodological details between studies. 
Here I report a systematic matrix of polyA-RNA-seq data that includes 12 tissues from 
E10.5 to P0 (Figure 2.1) and covers much of organogenesis and histogenesis. By 
comparing the transcriptome profiles along time axis and across tissue identity space, 
finer details on gene-regulatory network structures and mechanisms can be revealed. 
 
Figure 2.1: Tissues collected for whole-tissue RNA-seq assay. (A) Mouse embryo stages 










2.2.1 Overall structure of the high dimensional transcriptome 
As expected, the vast majority of protein-coding genes (84%) were significantly 
expressed (Figure 2.2), compared to a smaller fraction of lincRNAs (44%) and a minority 
of “other” annotated genes (26%) including many pseudogene, antisense, and small 
RNAs. This is probably due to the fact that protein-coding genes are better annotated 
while non-coding RNAs, especially those in “other” categories, are more likely to be 
mingled with pseudogenes and repetitive sequences. Current sequencing technology 
usually cannot perfectly quantify pseudogenes and repetitive sequences due to their lack 
of unique sequence information and the size limit of sequencing read length. lincRNAs 
stand in the middle of the spectrum, probably because they are longer and better 





lincRNAs and pseudogenes can be dynamically converted to each other during 
evolution128, further blurring their boundary.  
 
Figure 2.2: Number of genes detected by class. (A) percentages of ubiquitous, 
differential, and undetected genes in each of the three categories: PC (Protein-coding 
genes), lincRNA (long intergenic noncoding RNA), and others. (B) Percentages of PC, 
lincRNA, and other genes in detected and undetected categories. 
The detected transcriptome can be further divided into two parts: ubiquitous and 
differential. The highly differential character of the transcriptome comes from 15,644 

































9085 genes were more uniformly expressed, forming the foundation of ubiquitous 
housekeeping activities and structures (Figure 2.3). 
 
Figure 2.3: Hierarchical clustering of ubiquitous genes. Tissue identities and stages are 
labeled at the top using the color codes from Figure 2.1. 
To understand the main themes of the transcriptome, I conducted Principle Component 
Analysis (PCA) for these whole-tissue data. Overarching organizational themes of this 
mouse developmental transcriptome are tissue identity and developmental time, 
visualized as color hue and intensity shown in Figure 2.4A. The top three principle 
components separated tissues into roughly three domains: hematopoietic (liver, spleen, 
and thymus) domain, neurogenic (all three brain regions and neural tube) domain, and a 
third domain with all the remaining tissues in it. These domains were mainly separated by 





component based on Gene Ontology (GO) analysis of top 100 loading genes (Table 
2.1). Notably, the negative top-loading genes of PC1 were enriched with those associated 
with blood component, while the positive top-loading genes of PC1 yielded neurogenesis 
terms (Table 2.1). This indicates that the contrast between hematopoiesis and 
neurogenesis is the most outstanding feature in the differential transcriptome, confirmed 
by an independent t-SNE projection (Figure 2.4B). Interestingly, multiple tissues emanate 
from a “hub” and form “branches” (labeled with arrows in Figure 2.4A) and descend 
toward the negative direction of PC3 (to be discussed later in this chapter) with decreased 
similarity to each other, representing a gradual enhancement of their unique signatures. 
 
 
Figure 2.4: Whole-tissue transcriptome viewed at reduced dimensionality. Each tissue is 
labeled using the color code in Figure 2.1. The dimensions are respectively (A) the first 
three Principal Components from PCA and (B) the two axes of t-SNE two-dimensional 
plane. 
PC Negative loading P-value Positive loading P-value 
1 Blood microparticle 2e-22 Neuron part 2e-22 
2 Embryonic morphogenesis 4e-22 Blood microparticle 3e-35 





4 Digestive system process 1e-10 Contractile fiber part 1e-40 
5 Intestinal epithelial cell differentiation 5e-9 Skeletal muscle contraction 3e-12 
6 Muscle system process 3e-21 Apical plasma membrane 6e-14 
7 Neuron fate commitment 3e-11 A/P patern specification 2e-33 
8 Embryonic limb morphogenesis 1e-11 Hemoglobin complex 4e-14 
9 A/P pattern specification 7e-11 Lung development 3e-8 
10 Cerebral cortex neuron differentiation 1e-15 A/P pattern specification 5e-11 
11 A/P pattern specification 5e-37 Neuron differentiation 7e-11 
12 Urea cycle 1e-5 Cornified envelope 1e-11 
13 Embryonic forelimb morphogenesis 8e-9 NA >1e-5 
14 Striated muscle contraction 7e-7 Alpha-amylase activity 2e-9 
15 Embryonic morphogenesis 1e-11 A/P pattern specification 7e-22 
16 Contractile fiber part 8e-7 Monooxygenase activity 6e-20 
17 Neuron differentiation 1e-10 Blood microparticle 2e-22 
18 Alpha-amylase activity 2e-9 Intermediate filament 2e-9 
19 Monooxygenase activity 9e-11 Regionalization 3e-25 
20 Midbrain development 2e-12 A/P pattern specification 3e-17 
 
Table 2.1: Representative GO terms for top-loading genes of each PC for whole-tissue 
RNA-seq analysis. Negative PC’s are on the left panel and positive on right. 
Representative GO terms are listed in the corresponding boxes. 
In order to better understand the dynamics and specificity of the differential genes, I 
performed hierarchical analysis, identifying altogether 34 major clusters of co-expressed 
genes (Figure 2.5). These clusters mostly showed enriched biological themes based on 
Gene Ontology analysis of their gene members (Figure 2.6). Notably, most of these 
clusters have a trend of increasing abundance of genes, and upward genes are less likely 
to be shared among multiple tissues compared to downward genes. This pattern favors 
the model that embryonic histogenesis is mainly driven by differential activation of genes 
instead of differential repression of already active genes. 
For validation purposes, I compared PCA with hierarchical clustering results by mapping 
PC scores (Figure 2.5C) and loadings (Figure 2.5B) onto the gene-by-sample matrix. 
Indeed, the two largest clusters (Cluster 10 and Cluster 34) respectively load to the 




and neurogenesis. In fact, nearly 1/5 (~5000 genes) of the expressed transcriptome 
defines this axis, perhaps reflecting the elaborate branching cell lineages that produce, 
within this timeframe, exceptionally large repertoires of distinctive neuronal and 
hematopoietic cell types. Not surprisingly, their feature tissues show negative (thymus, 
spleen, and liver for Cluster 10) and positive (brain regions and neural tube for Cluster 
34) scores for PC1. Other PCs and clusters also showed a high degree of relatedness, 






Figure 2.5: Hierarchical clustering of differential genes. (A) Gene expression profiles 
across tissues. Normalized log2 FPKM values are represented by the colormap (bottom), 






skeletal muscle; Bld, bladder; Adr, adrenal gland; Kdn, kidney; Lng, lung; Stm, 
stomach; Int, intestine; Lmb, limb; Fac, craniofacial prominence; Fb, forebrain; Mb, 
midbrain; Hb, hindbrain; Nt, Neural tube. (B) PC loading coefficients of each gene in 
panel A. Normalized coefficients are shown using a heatmap with color scheme labeled 
in panel A. (C) PC scores of each sample in Panel A. Normalized coefficients are shown 
using a heatmap with color scheme labeled in panel A. Representative Gene Ontology 
terms are labeled on the right for negative and positive directions. 
 
Figure 2.6: Schematic view of cluster relationships. Rectangle boxes represent the 34 
major clusters, each of which contains more than 30 members. The text in each box 
labels the dominant features for each of these clusters based on Gene Ontology, tissue 
specificity, and gene class. The boxes in blue represent clusters with genes that mainly 
increase over time, while pink boxes are the opposite and green are constant; lavender 
indicates an unknown trend due to lack of time-course data; yellow boxes are genes 
without obvious dominant trends and are likely due to technical issues of the assays. The 
remaining dynamic genes fall into minor clusters with fewer than 30 genes per cluster, 





To rule out the possibility that the global structure is highly biased towards the choice 
of tissue I have (there are way more brain samples than digestive tissue, for example), I 
performed similar analyses, but with brain tissues down-sampled (only midbrains kept). 
The results were barely changed: PC1 was still about hematopoiesis vs. neurogenesis, 
which was still contributed by a large number of genes enriched in their corresponding 
tissues (Figure 2.7). The fine structures revealed by individual clusters were also 
consistent with the original analysis, which is going to be discussed in the next section. 
 
 
Figure 2.7: Validation of global transcriptomic structures by down-sampling. Results of 
hierarchical clustering (A) and PCA projection (B) of whole transcriptome with 











2.2.2 Diverse biological insights from co-expression clusters  
Hierarchical clustering produced 34 major clusters with different tissue specificity and 
temporal patterns, summarized in Figure 2.6. Each of them has its own unique expression 
patterns, enriched Gene Ontology terms, and complexities.  
 
Figure 2.8: Cluster 1 from hierarchical clustering analysis. Sample identities are labeled 
at the top with the code specified in Figure 2.1. 
Cluster 1 (Figure 2.8) has prominent increasing transcript abundance in limb and 
craniofacial prominence. Over one third of the genes in this cluster are genes coding 
keratin and keratin-associated proteins, with top GO terms “intermediate filament” 
(p=3.7e-34) and “hair cycle” (p=2.4e-7), pointing to development of skin and hair. This 






group of genes may be those specifically expressed in the skins of limb and 
craniofacial prominence that increase their proportion during development. 
  
Figure 2.9: Cluster 2 from hierarchical clustering analysis. Sample identities are labeled 
at the top with the code specified in Figure 2.1. 
Cluster 2 (Figure 2.9) has prominent expression in skeletal muscle and an increasing 
trajectory in limb and craniofacial prominence. It contains multiple muscle regulators like 
Myod1 and Myog. Its top GO terms include “muscle system process” (4.5e-18) and 
“contractile fiber part” (9.9e-14). The increasing expression in limb and craniofacial 
prominence is likely due to differentiation of muscle precursors and to increasing relative 
muscle mass as a fraction of the total tissue. In addition to the dominant muscle-limb-face 
feature, there are two clades with different patterns that illustrate the informational 






leverage that comes from the absence of expression in a more pure P0 dissected tissue 
(here muscle).  
The clade of 13 genes labeled in blue has increasing expression in limb and craniofacial 
prominence but not in the P0 pure skeletal muscle sample. Among the 13 genes, five 
(Dcstamp, Mmp13, Bglap, Ifitm5 and Ibsp) are associated in prior work with 
osteogenesis. Another clade of 13 genes labeled in purple is biased for limb alone, and 
not cranioface. It includes four major urinary protein (MUP) genes at low but detectable 
abundance. The mouse genome has 21 annotated Mup genes in a 2Mb cluster on 
Chromosome 4. Although none have human orthologs, members of the family have 
known functions in mouse chemical communication and nutrient metabolism129. A recent 
study reported dramatic and unexpected upregulation of Mup1 in mouse embryos when 
Shox2130, a transcription factor regulating proximal bone formation in limbs, is mutated. 
This raises the possibility that MUPs in this limb cluster play a role in limb development. 
Technical issues were also identified: sporadic samples of adrenal gland, kidney, lung, 
stomach, hindbrain, and neural tube from this mouse embryo series show slight 







Figure 2.10: Cluster 3 from hierarchical clustering analysis. Sample identities are labeled 
at the top with the code specified in Figure 2.1. 
Most genes in Cluster 3 (Figure 2.10) have high and constant levels of expression in the 
heart. Roughly half of them also have substantial expression in skeletal muscle-
containing samples, suggesting a program of genes shared by cardiac muscle and skeletal 
muscle. GO terms are mainly about muscle, including “contractile fiber part” (p=8.9e-47) 
and “regulation of heart contraction” (p=4.3e-21). Genes coding DMD, alpha-actins, 
Desmin, Leiomodins, myosin peptides, and troponins were found in this cluster. The 
clade in the upper half of the heatmap has narrow dark red bars, which indicate single 
replicate enrichment. This group of genes contains mostly pseudogenes. This may 
represent the limit of current sequencing methodology in quantifying the non-unique part 
of the transcriptome. 







Figure 2.11: Cluster 4 from hierarchical clustering analysis. Sample identities are labeled 
at the top with the code specified in Figure 2.1. 
Genes in Cluster 4 (Figure 2.11) show differing degrees of bladder-specific expression, 
which may result from a bladder-specific cell type that has a unique transcriptome 
signature. GO analysis produced no terms. A possible reason is that the mouse bladder 
has not been extensively studied. Under-annotation may compromise the statistical power 
of GO analysis in this case. 







Figure 2.12: Cluster 5 from hierarchical clustering analysis. Sample identities are labeled 
at the top with the code specified in Figure 2.1. 
Genes in Cluster 5 (Figure 2.12) are very prominently expressed in the thymus, and most 
have minimal expression in other tissues. Highly expressed genes also have positive 
signals in several non-thymus samples (at least 4 heart samples, 2 lung samples, and one 
neural tube sample), with atypical irreproducibility between replicates. A candidate 
explanation is a batch-specific contamination of thymus-proximate tissues with thymus 
during dissection. While this kind of contamination does not greatly alter global QC 
scores, it is readily detectable in this clustering analysis. GO analysis revealed enrichment 
in later stage maturing immune components, especially T-cell terms. Top terms include 
“immune system process” (p=1.8e-18) and “regulation of T-cell activation” (p=3.0e-13). 
Roughly one quarter of the genes are T-cell receptor components (alpha chain, gamma 






chain, and delta chain). Interestingly, the two recombinases Rag1 and Rag2 are also in 
this cluster, indicating a TCR VDJ theme for this cluster. 
 
Figure 2.13: Cluster 6 from hierarchical clustering analysis. Sample identities are labeled 
at the top with the code specified in Figure 2.1. 
The unifying theme of Cluster 6 (Figure 2.13) is high expression in the adrenal gland. 
Top GO terms include “hormone biosynthetic process” (p=1.5e-7) and “hormone 
metabolic process” (p=7.3e-7). More specifically, Cyp11b1, Cyp21a1, and Cyp11b2 
contribute to the term “mineralocorticoid biosynthetic process” (p=2.8e-7). These 
cytochrome P450 genes are involved in biosynthesis of aldosterone which, unlike many 
other hormones, is produced only in the adrenal gland. However, all of Cyp11b1, 
Cyp21a1, and Cyp11b2 mentioned above have detectable expression signals in E15.5 and 
E16.5 samples of kidney. Their presence at E15.5 and E16.5 stages and absence in E14.5 
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and P0 may be due to the fact that E15.5 and E16.5 samples were pooled dissections, 
while E14.5 and P0 samples were dissected from individual embryos by another lab, 
which were more contamination-free. The reason why other adrenal genes did not show 
up in those contaminated kidney samples is probably that those genes do not have as high 
abundance as these. 
 
Figure 2.14: Cluster 7 from hierarchical clustering analysis. Sample identities are labeled 
at the top with the code specified in Figure 2.1. 
Cluster 7 (Figure 2.14) has a theme of kidney-specific expression, where transcript 
abundances increase over time. Roughly 40% of these genes are also expressed in the 
liver, again with increasing trajectories, plus some smaller subclades that are shared with 
gut or lung samples. Top GO terms of this cluster include transporter-related categories 
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such as “sodium ion transport” (p=2.0e-14) and “anion transport” (p=4.7e-9) and 
structural terms like “apical plasma membrane”. Therefore, this cluster seems to be 
dominated by genes responsible for transporter machinery and epithelial cell organization 
in the kidney. The clade of 72 genes labeled in purple contains genes enriched in both the 
liver and kidney. The top enriched GO terms for this group are for amino acid catabolic 
processes performed in both the liver and kidney (“organic acid metabolic process” 
(p=7.7e-12), “fatty acid metabolic process” (p=1.2e-7), and “alpha-amino acid catabolic 
process” (p=1.5e-6). 20 of these genes are enriched in kidney proximal tubule brush 
border cells, while 7 are enriched in hepatocytes131. 
 
Figure 2.15: Cluster 8 from hierarchical clustering analysis. Sample identities are labeled 
at the top with the code specified in Figure 2.1. 






The genes in Cluster 8 (Figure 2.15) have increasing expression patterns in almost all 
tissues, although the kinetics of increase differ. Top enriched GO terms include 
“inflammatory response” (p=1.0e-6) and “extracellular exosome” (p=1.5e-5). There are 
two major clades. The clade labeled in purple is consistent with genes marking the 
immune system, whose levels are highest in the thymus and spleen, but also include 
expression in the hematopoietic fetal liver. Subsets of these genes increase at later times 
in other tissues. GO analysis called terms including “regulation of T cell activation” 
(p=8.8e-5) and “inflammatory response” (p=2.2e-5). The second major clade, labeled in 
blue, is dominated by increasing expression in liver and gut tissues. Top GO terms 
included “extracellular exosome” (p=3.3e-9) for unknown reasons. This group of genes 








Figure 2.16: Cluster 9 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
The genes in Cluster 9 (Figure 2.16) have the highest enrichment by far in the spleen and 
on the P0 liver (but not at earlier times). Moderate abundance is also seen in the adrenal 
gland and lung. There is minimal but detectable expression in all other tissues at P0, but 
very little at all times before birth. GO analysis did not yield significantly enriched terms, 
but more than half of the genes in this cluster are immunoglobulin components (kappa 
and lambda light chain variables, heavy chain variables, and constant regions), consistent 
with B-cell maturation, appearing in the liver, spleen, and in lesser proportions the lung 
and other lymphatic-containing dissections. 
 
Figure 2.17: Cluster 10 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 






Over 60% of the genes in Cluster 10 (Figure 2.17) are preferentially expressed in the 
liver, lower in CNS tissues, and variously detected in other tissues. The RNA abundances 
mainly increase with time, but with differing kinetics. Top GO terms of Cluster 10 
include the immune system, such as “immune system process” (p=4.8e-101) and 
“regulation of immune system process” (p=2.0e-62). The additional prominence of many 
genes in the P0 thymus and/or spleen, along with other non-CNS tissues, points to the 
lymphatic system.  
 
In addition to the main immune theme, four clades with distinctions emerged. The one 
containing 267 genes labeled in purple are most enriched in the liver, as well as the 
stomach and intestine, increasing over time. Its top GO terms focus on lipids, including 
“lipid metabolic process” (p=3.8e-13) and “lipid transport” (p=4.1e-11), pointing to 
metabolic functions shared by hepatocytes and gut tissues. 
The clade of 200 genes labeled in pink contains genes enriched in the spleen and liver 
only and points to erythropoiesis. Its top GO terms are mainly related to maturing red 
blood cells, such as “tetrapyrrole biosynthetic process” (p=1.2e-20) and “erythrocyte 
development” (p=3.9e-10). DNA motif analysis (to be discussed in detail in 2.2.5) of 
promoters in this clade revealed a significant enrichment of Tal1:Gata1, a known pair of 
regulators essential for hematopoiesis. 
Members of the clade of 91 genes labeled in blue are mainly expressed in the late-stage 




“steroid hydroxylase activity” (1.7e-20) and “steroid metabolic process” (p=5.3e-9). 
More than a quarter of these are protein-coding components of cytochrome P450, which 
are involved in steroid and drug metabolism. Additionally, six sulfotransferase genes are 
also in this group. Sulfotransferase plays an important role in the metabolism of drugs, 
hormones, and bile acids. 
Lastly, the clade of 155 genes labeled in yellow shows more constant levels through time 
in the liver, with additional expression detected in the adrenal gland, kidney, stomach, 
and intestine. Its top GO terms include “blood coagulation” (1.7e-29) and “alpha-amino 
acid metabolic process” (3.1e-12), with six coagulation factors, six complement factors, 
fibrinogens, and regulators (protein C and serpins)found in this clade. 
 
Figure 2.18: Cluster 11 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 






Genes in Cluster 11 (Figure 2.18) are most highly expressed in the intestine and are 
also enriched in the stomach, with sharing of genes with the kidney or CNS tissues. E14.5 
and P0 timepoints show lower expression for multiple clades, which likely reflects 
systematic dissection differences at the boundaries between the two gut tissues. Top GO 
terms are mainly about intestine structure, including “brush border” (p=2.3e-11) and 
“brush border membrane” (p=3.1e-9). Interestingly, out of 16 genes contributing to the 
term “brush border”, 8 are in the small clade of 43 genes labeled in purple. This clade 
also has prominent increasing expression in the kidney, representing a shared program of 
brush border genes between the kidney and intestine. Other terms include “sodium ion 
transport” (p=1.0e-6), “digestive system process” (p=1.0e-6), and “alpha-amylase 




group, such as cholecystokinin, gastrin, vasoactive intestinal polypeptide, ghrelin, 
glucagon, and insulin genes.  
 
Figure 2.19: Cluster 12 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Most genes in Cluster 12 (Figure 2.19) are expressed widely and with an increasing trend, 
except in the liver, where most of the cluster is depleted at all times. The most prominent 
secondary theme is strong up-regulation at birth in multiple organs. Although no GO 
terms were significantly enriched, this cluster, and sub clusters within, are candidates for 
novel DNA sequence motif-derivation or for correlated microRNA signatures that could 
mediate the birth transition pattern and/or the liver suppression pattern. 
Normalized	
log2	FPKM N=536





Figure 2.20: Cluster 13 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Gene expressions in Cluster 13 (Figure 2.20) are mostly enriched in the lung, especially 
at later stages. Partly because of the small cluster size, Gene Ontology did not provide 
highly significant terms. However, 4 surfactant-associated proteins contributing to the 
term “multi-vesicular body” (p=4.3e-6) are included in this cluster, indicating a possible 
link to Type II alveolar cells in the lung. 
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Figure 2.21: Cluster 14 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Cluster 14 (Figure 2.21) contains genes that are highly expressed in the stomach. Most 
are also highly expressed in limb and craniofacial prominence at very late stages. About a 
quarter of them are expressed in the P0 bladder as well. The top GO terms are “cornified 
envelope” (p=6.7e-26) , “keratinization” (p=1.7e-27), “epidermis development”, and 
“keratinocyte differentiation” (p=1.6e-16). The cornified envelope is composed of a layer 
of dead cells found in the skin epidermis and forestomach for protection against the 
environment. Its major components include loricrin, filaggrin, involucrin, keratins, and 
small proline-rich protein (SPR) genes that are all found in this cluster, together with the 
genes required for generating the cornified envelope, such as transglutaminase, cystatin, 
and envoplakin.  
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Figure 2.22: Cluster 15 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Genes in Cluster 15 (Figure 2.22) are coherently enriched in specific samples, but they do 
not reproduce between replicates or among related tissues. Almost all genes in this cluster 
are known pseudogenes or protein-coding genes with low mappability. These low-
mappability genes’ top-abundance mappable counterparts (their corresponding protein-
coding genes or paralogs) do not display similarly variable enrichment, which argues that 
the differences are not due to the obvious source of biological variation (data not shown). 
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Figure 2.23: Cluster 16 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
The broad theme of Cluster 16 (Figure 2.23) is expression in most tissues and organs, 
with the exception of the CNS and liver, both of which show little expression. Over the 
developmental time course, most members increase in limb and craniofacial prominence 
but are relatively invariant or decreasing in other tissues. The top GO terms of Cluster 16 
are dominated by extracellular matrix (ECM) components, such as “extracellular matrix” 
(p=8.7e-58), “extracellular region part” (p=6.0e-42), and ‘’basement membrane” (p=4.4e-
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34). Other significant terms include “regulation of cell migration” (p=8.0e-26), 
“angiogenesis” (p=1.1e-25), and “cell junction” (p=2.3e-18).  
This cluster contains two major clades, highlighted in purple and blue, that share 
expression in the bladder, kidney, lung, stomach, intestine, limb, and craniofacial 
prominence. The blue clade is distinct in also showing strong expression in the heart. 
Their GO terms identify different biases. The purple clade features “occluding junction” 
(p=7.6e-9) in addition to ECM terms, while “angiogenesis” is absent. The blue clade 
includes most of the Cluster 16-themed terms, but also emphasizes “anchoring junction” 
(p=7.3e-19) and particularly “adherens junction” (p=3.0e-18), consistent with 
epithelial/endothelial cell junction formation and tube morphogenesis. Thus the purple 
clade focuses on tight junctions that consist of an epithelial barrier and molecular gate 
between a cell mass and the environment, while the blue clade concentrates on 
angiogenesis and adherens junctions that link cells together and also carry cadherin 





Figure 2.24: Cluster 17 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Cluster 17 (Figure 2.24) is divided into two major clades. The upper clade, similar to 
cluster 15, is coherently enriched in a few individual samples that do not replicate, nor do 
they reproduce among related tissues. Apart from these individual samples, the pattern is 
noisy across developmental time. This pattern does not correspond to any known 
dissection or global quality issue. Also similar to Cluster 15, no GO term enrichment was 
found. The lower clade contains genes that are widely expressed among different tissues 
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that are also systematically depleted in the E11.5 and E14.5 samples. This reflects 
known batch effects at tissue collection/dissection steps. 
 
Figure 2.25: Cluster 18 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Most genes in Cluster 18 (Figure 2.25) are enriched in the craniofacial prominence at 
early stages but not later. Its top GO terms mainly concern eye development, including 
“structural constituent of eye lens” (p=1.6e-17) and “eye development” (p=1.1e-15). 
Genes include crystallins, retinoic acid-metabolizing enzymes (Cyp26a1 and Cyp26c1), 
lens membrane protein (Lim2), melanin regulators (Tyrp1, Tyr and Pmel), and one 
developmental regulator (Vax2). The dissection plan for cranioface was to exclude the 
eyes, but at earlier stages it appears not to have been fully successful. The expression 
pattern and Gene Ontology of Cluster 18 genes in the early craniofacial prominence 
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samples (E10.5, E11.5 and E12.5) including sharp transitions between adjacent 
timepoints, are likely due to imperfect removal of early eyes. Sporadic enrichment of 
these genes in later stage craniofacial prominence samples (E16.5) is likely due to a few 
imperfect dissections in a large embryo pool. 
 
Figure 2.26: Cluster 19 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Genes in Cluster 19 (Figure 2.26) are mostly enriched in the bladder, kidney, limb, and 
neural tube. Within these tissues, expression levels are relatively constant over 
developmental time. The lower half of this cluster contains 5’ Hox genes (9-13) and 
lincRNAs localized in the 5’ region of Hox clusters (Hotair and Hottip). Genes with 
names beginning with “Gm” that are clustered together with Hox genes are also localized 
in 5’ Hox gene regions, suggesting shared transcriptional regulatory elements or RNA 
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precursors. Among these Hox-cluster genes, there are distinctions, with 5’ Hox 
expression being more abundant in posterior tissues (e.g. bladder, kidney, and intestine), 
consistent with previous findings. As the time course begins at E10.5, I could not follow 
the well-known upregulation sequence of Hox genes which displays “temporal co-
linearity”, except for a gradual increase in Hoxc12 and Hoxc13 in the limb, which 
represents the distal ends of limbs and whose upregulation pattern is late enough to be 
captured in our time window. In E14.5 neural tube samples, the 5’ most Hox genes 
Hox11-13 are missing-because that batch of embryo dissections did not include the 
posterior tip of the tube.  
Four major urinary protein (MUP) genes are enriched in the limb, similar to the MUP 
paralogs in Cluster 2. However, unlike those in Cluster 2, they are also enriched in early 





Figure 2.27: Cluster 20 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Overall, genes in Cluster 20 (Figure 2.27) are prominently absent from the liver at all 
stages and are absent or strongly reduced at P0 in most tissues having P0 data. The top 
~1/3 of the cluster contributes little to the two major themes derived from expression and 
GO. It contains mainly pseudogenes and lncRNAs. In the limb, craniofacial prominence, 
and brain, depletion of some of these genes is evident at E11.5 and E14.5 similar to 
Cluster 17, and possibly related to the batch effect discussed before. In the remaining 
bottom 2/3, there is considerable substructure among expressing tissues due to the two 
major biological themes: the first GO enrichment theme is tissue morphogenesis and 
development, such as “skeletal system morphogenesis” (p=3.3e-13), “branching 
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morphogenesis of an epithelial tube” (p=5.5e-12), “sensory organ development” 
(p=7.7e-11), “odontogenesis” (p=1.3e-10), “gland development” (4.5e-10), “ossification” 
(p=9.1e-10), “limb morphogenesis” (p=2.1e-9), and “kidney development” (6.1e-9); the 
second GO theme is Wnt signaling, such as “regulation of Wnt signaling pathway” (8.2e-
12), “Wnt signaling pathway” (2.0e-10), and “Wnt-protein binding” (3.2e-10). Although 
this cluster called terms covering a variety of different aspects of development 
demonstrated in the first theme, the driving genes are often shared among multiple terms 
referring to different tissues. This likely reflects the broad usage of these signaling 
pathways in patterning and morphogenesis. Moreover, roughly a quarter of the genes 
contributing to any morphogenesis-theme terms also contributes to the Wnt theme. Other 
morphogenesis-theme genes that do not currently contribute to the Wnt GO terms, such 
as Irx3, Runx2, TWIST, Bmp4, Tbx1, and Tbx3 have been independently associated with 
this signaling system. This is consistent with the current appreciation that Wnt signaling 
plays an important and widely distributed role in different individual anlage, including 
stem cell renewal132. 
The clade of genes colored in purple are highly enriched in kidney and moderately 
enriched in limb and craniofacial prominence. The themes are suggested by Gene 
Ontology with terms “skeletal system morphogenesis” (p=1.2e-6) and “branching 
morphogenesis of an epithelial tube” (2.3e-6). These terms of this clade are consistent 
with the overall theme of this big cluster, but the distinct gene expression pattern suggests 
intensive usage of this subprogram of genes in the kidney. The clade of genes labeled in 




detectable and decreasing in other tissues. The top GO terms are similar to those called 
from the whole cluster, but with much enhanced significance for “embryonic skeletal 
system morphogenesis” (p=1.8e-15) and “cartilage development” (p=1.5e-9). 
 
Figure 2.28: Cluster 21 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Genes in Cluster 21 (Figure 2.28) are expressed in all the fetal tissues and decrease over 
time in most. At P0, the majority are expressed in the thymus and spleen but are notably 
depleted elsewhere. Top GO terms are mainly about cell division and nucleus 
components, such as “chromosomal part” (p=1.2e-93) and “cell cycle process” (p=1.6e-
87) consistent with genes involved in executing the cell cycle, especially components of 
the chromosome and its associated proteins. The global decrease in RNA levels from 
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these genes over time is consistent with shifting from fast growing proliferating cells to 
more differentiated ones. Fetal hemoglobins are also found in this cluster, such as Hbb-
bh1, Hbb-y, and Hba-x.  
 
Figure 2.29: Cluster 22 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Genes in Cluster 22 (Figure 2.29) show distinct enrichment at E11.5 and E14.5 stages in 
some tissues, and they do so reproducibly among the replicates. Most of these genes are 
pseudogenes and low-mappability protein-coding genes. They are similar to the batch-
effect heavy clades in Cluster 17 and Cluster 20 but display the inverse pattern trend. 
They may be artifacts from a similar type of batch effect. 
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Figure 2.30: Cluster 23 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Cluster 23 (Figure 2.30) contains genes most prominently expressed at early times in 
CNS tissues. They are also depleted preferentially at E16.5 in many other tissues. Unlike 
the candidate batch effects of clusters like 15, 17, and 22 that are heavily enriched in 
pseudogenes, this cluster is not explained by annotated pseudogenes. There was no 
significant GO enrichment, and batch effect might be a cause of the expression pattern. 
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Figure 2.31: Cluster 24 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1 
Genes in Cluster 24 (Figure 2.31) are widely expressed and are preferentially higher in 
the CNS regions and/or in the developing liver. Most, but not all, increase during 
development of these tissues. Top Gene Ontology terms are dominated by lipid 
metabolism, such as “lipid metabolic process” (p=2.7e-13) and “cholesterol biosynthetic 
process” (p=1.7e-11). Interestingly, all of the nine genes contributing to the term 
“cholesterol biosynthetic process” are localized in a tiny clade of 23 genes labeled in 
purple. These 23 genes are all very abundant and highly correlated among themselves. 
Further research may contribute to the shared metabolic mechanisms between liver and 
CNS tissues. 







Figure 2.32: Cluster 25 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
More than half of the genes in Cluster 25 (Figure 2.32) are consistently and highly 
enriched in the hindbrain and neural tube plus the stomach, intestine and adrenal gland. 
The Kidney and lung also express distinct subsets of these genes. This cluster contains 
most of the 3’ Hox genes, almost all located in the two clades labeled in purple and blue. 
The purple clade consists of the 3’ most Hox genes and genes sitting in the 3’ end of Hox 
gene clusters, while the blue clade is made of Hox genes and non-Hox genes in the center 
(less 3’ but not 5’) of Hox clusters. The purple-clade genes are expressed in the lung 
while the blue ones are mostly not. This is probably because the lung is relatively anterior 
to other endoderm tissues assayed, which correspond to the 3’ end of the endoderm Hox 
A/P axis. For the genes outside the Hox gene clades combined, Gene Ontology generated 






terms related to the neural system, such as “neuron differentiation” (p=1.4e-7), 
focusing on “enteric nervous system development” (p=2.4e-7). In E14.5 neural tube 
samples, some genes are more depleted compared to E13.5 and E15.5. I think this might 
result from a dissection protocol detail that produced shorter spinal cords and depleted 
the 3’-most Hox expressing tissue. 
 
Figure 2.33: Cluster 26 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Genes in Cluster 26 (Figure 2.33) are mostly enriched in the forebrain at late stages. Avp 
and Oxt encode neuropeptides synthesized in the hypothalamus that regulate complex 
maternal and sexual behaviors133. They are clustered together within 6kb on chromosome 
2. It would be interesting to further study the relationship between these two genes and 
others in this cluster. 
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Figure 2.34: Cluster 27 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Cluster 27 (Figure 2.34) contains genes highly enriched in the kidney. Most are also 
expressed in the brain and neural tube at later stages but less abundantly than in kidney. 
Pax2, Pax8, and their target Gata3134 are found in this cluster, which specify the nephric 
lineage and regulate branching morphogenesis in the developing kidney. Pax2 and Pax8 
are also reported to specify GABAergic and glycinergic neuronal fates135, partly 
explaining expression in the hindbrain and neural tube. It is possible that this cluster 
concerns two independent cell fate specification and morphogenesis programs that use 
overlapping regulatory factor sets, such as Pax2, Pax8, and Gata3.  
Normalized	
log2	FPKM N=68








Figure 2.35: Cluster 28 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Genes in Cluster 28 (Figure 2.35) are expressed in many tissues, but with lung and 
craniofacial prominence being highest, followed by CNS regions. Almost all increase 
over time, but with differing kinetics in different tissues and brain regions. Most of the 
significant GO terms are about ciliogenesis, such as “cilium movement” (p=1.4e-19), 
“cilium” (1.2e-17), and “outer dynein arm assembly” (1.5e-14). The contributing genes 
include components of dynein arms and radial spokes, genes coding for assembly 
machinery such as dynein docking complex and the tubulin modifying enzyme, and the 
nexin-dynein regulatory complex. Two known cilium regulators, Foxj1 and Mcidas136, 
are also in this cluster. The cilium is a fundamental structure, with primary cilia being 
ubiquitous while secondary and sensory cilia having more specialized distributions›137 
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that correspond well with the pattern for the majority of genes in Cluster 28. The 
pattern can be explained by the emergence of airway cilia in the lung, the airways of the 
craniofacial prominence, and the ependymal cilia of the CNS. 
 
Figure 2.36: Cluster 29 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Most genes in Cluster 29 (Figure 2.36), a relatively small cluster, are distinguished by 
highest expression in the thymus, but more than half are also expressed substantially in 
the brain or in the face/limb or in the kidney/lung and gut. Gene Ontology failed to 
identify a significantly enriched term for this group, probably due to small sample size. 
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Figure 2.37: Cluster 30 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Cluster 30 (Figure 2.37) contains genes expressed most prominently in the heart and/or 
CNS samples, with the admixture among the tissues varying across different clades. Top 
enriched GO terms mainly identify transport of metal ions, such as “metal ion transport” 
(p=4.1e-8), “metal ion transmembrane transporter activity” (p=1.3e-7), and “potassium 
ion transmembrane transporter activity” (p=2.0e-7).  
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Figure 2.38: Cluster 31 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Genes in Cluster 31 (Figure 2.38) are mainly enriched in the brain and neural tube, with 
different regionalization for sub-clusters, plus facial prominence (perhaps partly driven 
by cross-contamination of face with forebrain dissection at early times). More than a third 
of the genes in this cluster are transcription factors (“sequence-specific DNA binding”, 
p=1.0e-26), most of which also contribute to the GO term “neuron differentiation” 
(p=4.4e-18). It is likely that this group of genes is involved in neuron maturation, such as 
Dlx1, Dlx2138, as well as Helt, which specifies GABAergic neuron differentiation139. 
Genes responsible for cerebral cortex GABAergic interneuron migration (Lhx6140, 
Arx141, and Fezf2142) are also found in this cluster. 
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Figure 2.39: Cluster 32 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Genes in Cluster 32 (Figure 2.39) are expressed in nearly all the tissues with increasing 
trajectories over time, with the notable exception of the liver where they are expressed at 
very low levels and then decrease. This cluster contributes to the global separation of the 
CNS (where expression is strongest) from the developing liver. Gene Ontology offered 









Figure 2.40: Cluster 32 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
Genes in the large Cluster 33 (Figure 2.40) are expressed in most tissues prior to P0, 
except liver. CNS, face, and limb are by far the most prominent. Most of these genes are 
time-course variant. Time courses in different tissues display distinctive trajectories, with 
decreasing courses being more common, unlike most other major clusters. Thus, genes in 
this cluster vanish very early in the liver; decrease monotonically in the kidney, lung, 
stomach, and intestine; and remain constant early and slightly decrease at later stages in 
the heart, craniofacial prominence, and limb. Gene Ontology enrichment produced three 
major themes. First, 159 genes (16%) encode DNA binding proteins - especially 
transcription factors - contributing to “DNA binding” (p=1.7e-17) and “RNA 
biosynthetic process” (p=7.5e-14). Zinc finger presumptive repressors143 are especially 
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prominent (Figure 2.47C). Second, this cluster contains genes regulating different 
aspects of morphogenetic processes, with enrichment in the term “embryonic 
morphogenesis” (p=1.9e-12). This is similar to Cluster 20, which also has a broadly 
decreasing pattern, though it features an emphasis on the Wnt pathway that does not 
apply to Cluster 33. Finally, significant overlaps of Cluster 33 with cell projection-related 
genes are called by terms “cell projection organization” (p=1.3e-15), “cilium assembly” 
(p=1.9e-14), “neuron projection guidance” (p=4.4e-11), and “regulation of nervous 
system development” (p=4.2e-12). This cluster of genes is different from the cilium-
related Cluster 28 in expression dynamics, showing opposite temporal trajectories that 
argue strongly for distinct regulation. Further studies would be desired to dissect this 
complex cluster. 
 
Figure 2.41: Cluster 34 from hierarchical clustering analysis. Sample identities are 
labeled at the top with the code specified in Figure 2.1. 
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The theme of Cluster 34 (Figure 2.41) is expression in all four CNS tissues, with a 
dominant upward temporal pattern. While most increase over time, they do so with 
varying kinetics among subclades and between brain regions. Gene Ontology revealed 
enrichment for a large number of neuron-identity and structure terms associated with 
neuronal differentiation and maturation, with the most dominant ones being “synapse” 
(p=1.0e-93), “neuron projection” (p=6.9e-55), “behavior” (p=2.3e-42), and “regulation of 
nervous system development” (p=2.9e-34). Apart from the central neuronal theme, 
subclades (colored purple, blue, and pink) differ from each other and from the major 
neural cluster. All three are significantly enriched with transcription factors and neural 
development regulators, and they display diverse tissue patterns relative to each other. 
The small purple clade at the top (next to the blue clade but too small to see clearly) 
features genes enriched caudally in neural tube and hindbrain. The blue clade below it is 
enriched in the midbrain and significantly but less so in the hindbrain and neural tube, 
with overall downward trajectories. The pink clade near the bottom features genes 
expressed earliest in all four CNS regions, diminishing in later stages.  
2.2.3 Additional implications from other expression patterns  
Although most of the genes are categorized as members of major clusters, 441 of 15747 
differential genes cannot join any major clusters due to their eccentric expression patterns 
and thus join smaller clusters. Two models may explain this phenomenon. First, these 
transcripts may be produced due to stochasticity either from random transcription or 
unknown technical issues in library construction or quantification. Indeed, there are a lot 




might be biological or technical noise that never robustly showed insightful patterns in 
existing studies. Secondly, these genes may actually have functions but they do not have 
a multi-target regulator to bring in other co-regulated targets into the group (unlike 
Cluster 28 in which Foxj1 regulates multiple cilium-related genes to join that cluster). 
One interesting minor cluster between Cluster 26 and Cluster 27 contains three beta-
defensins in it (Figure 2.42). Defb9, Defb10, and Defb 11 are prominently expressed in 
the hindbrain and are also detectable in the forebrain. A previous study found Defb10 and 
Defb11 expressed in adult and neonate brains but barely in other tissues like kidney, 
while Defb9 was found present in adult hippocampus144. Defb11 was also predicted to be 
related to Alzheimer’s disease145 and was believed to be positively regulated by Tau, a 
neuronal phosphoprotein responsible for neurofibrillary tangles formation146. Although 
mouse beta defensins had gone through their own recent evolutionary changes144, it 
would still be interesting and promising to study how human beta defensins contribute to 
Alzheimer’s disease in human brains147. 
 
Figure 2.42: Genes between Cluster 26 and Cluster 27 from hierarchical clustering 






In addition to these differential genes in or out of major clusters, 9085 genes were 
more uniformly expressed (Figure 2.3) across identity and temporal domains, which 
account for 36.6% of genes detected in this study. Although this is relatively lower than 
in most other studies, I believe it is because the data collection here covered many 
distinct developmental processes and cell types so that many more differential features 
were captured. Even so, ENCODE3’s collection of mouse tissue samples is not complete 
either, meaning that more differential features might be discovered in the future. Our 
current estimation of the percentage of ubiquitous genes is only an upper-bound for the 
real fraction. Genes currently viewed as ubiquitous in our annotation may turn out to be 
highly enriched or depleted in a different tissue that was not assayed by ENCODE3. One 
such example might be mouse testis, since most of the orthologs of human testis-specific 
genes16 were not prominently detected in ENCODE3 mouse samples (Figure 2.43). 
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Figure 2.43: Mouse orthologs of human testis-specific genes. Sample identities are 
labeled at the top with the code specified in Figure 2.1. The heatmap shows Log2-
transformed FPKM values based on the color scheme on the left. 
Another notable feature of the ubiquitous genes I defined in this thesis is that they 
generally have a downward trend in terms of abundance (Figure 2.3), although the fold-
change threshold was set to be symmetric. This indicates a systematic drift in their 
measurements. In fact, as mentioned before and visualized in Figure 2.6, much more 
differential gene clusters show increasing patterns than those with decreasing patterns. 
Therefore, the transcriptome might become more dominated by differential genes that are 
tuned up at later time points (Figure 2.43A) in terms of relative abundance. It is possible 
that overall more differential genes get transcribed as development progresses such that 
ubiquitous genes just simply get diluted. As a control, when constructing RNA-seq 
libraries, a constant amount of spike RNAs was added to total RNAs at a fixed ratio. If 
the dilution hypothesis is true, the spike fraction would have a similar decreasing pattern. 
However, it has a different pattern (Figure 2.43B). Tracing the quantification of 
individual spike level also failed to explain the decreasing trend of ubiquitous genes (data 
not shown). Therefore, the ubiquitous genes are probably not constant. They gradually 
decrease in multiple tissues. In fact, they also show weak tissue-specificities such as a 
slightly higher level of mitochondria genes in the heart and a slightly higher level of 
metabolism-related genes in the liver (data not shown). This challenges the existing view 
of ubiquitous genes which treats them as constantly expressed house-keeping units and 
thus calibration references. In fact, “house-keeping” genes may also have biases and 




for a protein to do. But with the stringent 10-fold threshold defining differential genes 
in this thesis, the analyses of differential transcriptome should be minimally related to 
house-keeping functions. 
 
Figure 2.44: Proportions of reads for genes and spikes. (A) The ratio of reads mapped to 
differential genes over both ubiquitous and differential is visualized as a vertical bar in 
blue while the yellow part represents the remaining ubiquitous genes’ reads. Tissue 
identities on x-axis are labeled at the bottom, using the color code in Figure 2.1. (B) The 
fraction of reads mapped to spikes among all the mapped reads is visualized as a vertical 
bar in blue while the yellow part represents the part of reads mapped to endogenous 
genes. Tissue identities on x-axis are matching those in (A). 
2.2.4 Sources of technical artifacts. 
In session 2.2.2, I briefly mentioned various artifacts due to dissection protocols, which 
can be summarized into six types, namely, muscle contamination (Figure 2.9), thymus 
contamination (Figure 2.12), incomplete removal of adrenal gland from kidney (Figure 














2.13), differences in gut tissues’ anatomical definition between labs (Figure 2.18), 
failure to remove the eyes from craniofacial prominence (Figure 2.25), and differences in 
neural tube dissection between labs (Figure 2.26 and Figure 2.32). In our ENCODE3 
meetings, our lab was the only one that could identify these six types of artifacts, while 
labs producing chromatin data and DNA methylation data could not. This might reflect 
the superior sensitivity of RNA measurements compared to DNA and chromatin-based 
measurements where contamination signals could be diluted by numerous other nuclei 
with negative signals. This is because a contaminating cell may carry a large number of 
transcripts for a gene but can only carry two copies of DNA for it. Another explanation is 
that RNAs are much better annotated, so it is easier to explain strange patterns, while 
DNA loci are poorly understood, especially those in intergenic regions. But, my finding 
of experiment-based artifacts does provide important information for analyses of 
chromatin and DNA methylation data of the matching samples to reach careful 
conclusions.  
A second group of artifacts are specific to either certain replicates in certain tissues 
(Figure 2.10, 1.22, and 1.24) or certain developmental time points (also correlated with 
production time) in certain tissues (Figure 2.24, 1.27, 1.29, and 1.30). These artifacts 
usually come in the form of inconsistent levels of pseudogenes and other low-mappability 
genes. Computational choreography (how the codes and their dependencies were run and 




difference might be one reason, but the real cause is still unknown despite my efforts to 
try to figure it out before this thesis was due.  
A third group of inconsistencies comes from the fact that tissues at E14.5 and P0 were 
dissected from individual embryos instead of pooled embryos by Wold lab, for numerous 
logistic reasons. That created a new layer of information: sex. Although it was difficult to 
determine the gender of early embryos, sex-specific genes still contain that information. 
Using Xist148 and Ddx3y149 as gender markers, I found that pooled samples always 
contained both genders while individual embryos always had a single clear gender 
(Figure 2.44).  
 
 
Figure 2.45: Inferred genders. (A) The FPKM values of Ddx3y and Xist in each sample 
are shown on the scatter plot at log scale with a linear model shown as a curved line. Data 
points sitting on X-axis are females while those on Y-axis are males. The remaining dots 
are mixed pools. (B) The gender of each sample is labeled using different colors (pink, 
female; blue, male; lavender, both). ID’s of each individual embryo at E14.5 and P0 are 
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715.2.1717.2.1pool pool pool pool 722.2 722.1
715.2.1717.2.1pool pool pool pool 722.1 722.2
717.2.1715.2.1pool pool pool pool 1112 1112










To further get a global view of batch effects, I used a principal component analysis – 
canonical correlation analysis (PCA-CCA) approach61,60, to find a parsimonious 
relationship between major principal components and metadata. Developmental stages, 
tissue identities, gender identity based on gender-exclusive genes, and putative thymus 
contaminated samples defined by thymus-exclusive genes were marked down using 
Boolean variables (1 or 0). Scores of the top 20 principal components of log-transformed 
transcript FPKM values together with the Boolean variables were used for canonical 
correlation analysis (CCA). The results were summarized in Figure 2.46.  
Similar to previous PCA results, CCA still ranks the contrast between liver and brains as 
the most important component (Figure 2.46A). In fact, PC1 strongly negatively 
contributes to the top 1 canonical variable (U1) (Figure 2.46C), reflecting a differential 
blood component.  
Among the top canonical variables, the third pair corresponds to a batch effect specific to 
E11.5 and E14.5 samples across multiple tissues (Figure 2.46A and B). Based on the 
gene expression patterns of high loading genes on both ends of the V score spectrum, I 
identified a clear depletion pattern at both E11.5 and E14.5, corresponding to Cluster 17, 
which is likely a product of the early dissection batch effect. In fact, 16 of the top 100 
negative loading genes are from Cluster 17 (P = 4.7e-13, Fold Enrichment = 11.75). 




variables that compromise the former, this batch effect isn’t profound in terms of 
E14.5 loadings. 
Among our ENCODE mouse tissue samples, subsets of heart, lung, and neural tube 
samples have shown thymus-specific genes expressed probably due to contamination. In 
my CCA, the fifth and eighth pairs have strong loadings from the variable labeling 
thymus contamination in Figure 2.46B. Among all the tissue identity variables, thymus 
identity is the only outlier that stands out in both pairs of canonical variables, confirming 
that contamination is not likely from another tissue, but instead, thymus. In fact, a large 
number of T cell receptor fragments are found in negative loading genes of U5 and 
positive loading genes of U8, corresponding to negative loading of thymus identity and 
thymus-contamination variables to V5 and positive loading of them to V8. Since tissues 
at E14.5 and P0 for RNA-seq assay were dissected from individual embryos instead of 
pools for samples at other timepoints, potential biases from gender and quality may be 
present in the samples. These biases are associated with the two variables labeling “male” 
and “female”. I observed that both “male” and “female” variables highly and almost 
equally contribute to the sixth pair of canonical variables (Figure 2.46B). It is also 













































Figure 2.46: Canonical correlation analysis of whole-tissue RNA-seq samples. 
Principal component scores of log-transformed gene expressions and metadata 
information are used as two sets of variables for canonical correlation analysis. (A) 
Horizontally normalized scores of the set of canonical variables (U scores) corresponding 
to principal components are plotted based on the color scale shown on the right. Columns 
indicate tissue and stage identities matching the color code in Fig. 1.1. (B) Vertically 
normalized loadings of each metadata variable for their corresponding canonical 
variables (Vi) are plotted based on the color scale shown on the left. (C) Vertically 
normalized loadings of each PC for their corresponding canonical variables (Ui) are 
plotted based on the color scale shown on the right. 
After scanning through the top loading genes for U6, I identified a strong depletion of 
negatively loading genes. Interestingly, these genes are highly enriched in blood-related 
GO terms, indicating that the individual embryo dissections (from Wold lab) may have 
carried over a smaller amount of blood than the pool dissections.  
Among the 18 pairs of canonical variables that have high correlations (Correlation 
coefficient >0.7), the 18th pair showed a strong difference between the loadings of 
“male” and “female” variables (Figure 2.45B). By checking the high loading genes to 
each end, I noticed that male-specific genes (Eif2s3y, Ddx3y, etc.) and female-specific 
genes (Xist, Tsix, etc.) are respectively contributing to two opposite sides of the 
canonical variable. However, since the magnitude of loadings quickly drops off as I go 
down the list of the high-loading genes, and since the “male” and “female” variables are 
only contributing to the weakest pair (18th) of variables that sits at the edge of our 
detection range, I regard gender bias as very minimal and only limited to a small set of 






Overall, the technical artifacts mainly come from dissection issues and unknown 
inconsistent quantifications of low-mappability genes. Gender difference in individual 
dissects is a very minor factor, and it only affects a small number of genes. 
2.2.5. Mechanisms of transcriptional regulations of differential genes 
Transcription factors play a very important role in the regulation of transcription. Based 
on animalTFDB 2.0150, there are altogether 1485 transcription factors. These transcription 
factors also show tissue identity and temporal specificity, similar to but not necessarily in 
the same way as the global gene pattern (Figure 2.46A and B compared to Figure 2.4B 
and Figure 2.5A). Different families of transcription factors do not share the same 
distribution across differential gene clusters. Cluster 33 (Figure 2.40), which is associated 
with embryonic morphogenesis and neuron projection, is the cluster most significantly 
enriched with transcription factors, especially C2H2 zinc finger proteins. The biological 
function of many of these zinc finger factors are still poorly understood. Homeobox 
transcription factors are not only significantly enriched in Hox gene clusters (Cluster 19 
and Cluster 25, Figure 2.26 and Figure 2.32) but also in clusters associated with eye 
development (Cluster 18, Figure 2.25) and neuron differentiation (Cluster 31, Figure 
2.38). This may relate to their general role of axis definition and tissue regionalization, 
and imply more specialized roles of Homeobox factors. IRF factors are enriched in 
Cluster 10 that features liver expression and hematopoiesis. E2F factors are highly 




regulate cell proliferations. Motif analysis to be mentioned later also confirmed this 
relationship.  
Patterns of RNA co-expression are caused, at least in part, by transcriptional co-
regulation. To systematically evaluate how transcription factor (TF) bindings affect gene 
expression patterns, I focused an initial global exploration on proximal promoters 
(500bp) by testing each cluster for enrichment of all 718 known consensus TF binding 





Figure 2.47: Transcription factor expressions in the whole-tissue RNA-seq data. (A) 
PCA projection of transcription factor expression profiles. (B) One-way hierarchical 
clustering of transcription factor expressions in whole-tissue data. Tissue identities are 
labeled with color codes in Fig. 1.1. (C) Counts of transcription factors from each family 








Figure 2.48: DNA Motif analysis of expression cluster proximal regulatory regions. (A) 
Flowchart of the analysis. TSS upstream sequences for each cluster were used to derive 
enriched motifs. (B) Bloom graph summary of unique and shared enrichment. Motifs and 
gene cluster identities are labeled as nodes. Enrichment is visualized as connecting lines 
between a motif and a gene cluster whose thickness indicates significance. Motifs 
enriched in more than one cluster are highlighted in gray instead of yellow. The sizes of 
gene cluster nodes represent the numbers of genes in the corresponding clusters.  
The results were organized as a bloom graph, with patterns of motif-sharing between 
clusters shown as connected, shaded TF nodes or pedals (Figure 2.47B). Thus, one 
“flower” represents the collection of putative regulators of a single cluster. 307 motifs 
were significantly enriched in at least one cluster, including biologically sensible TF 






hematopoietic (GATA, Tal and IRF), hepatic (HNF4a, and Prox1), and bile duct 
factors (HNF6, HNF1b, Sox9); the highly specific Rfx factor family belongs to its cilium 
cluster (Cluster 28, Figure 2.35); and the E2F family is prominent in the previously 
discussed cell cycle-theme Cluster 21 (Figure 2.28). 
The bloom graph also showed large-scale patterns: the prominent separation of 
neurogenesis (Cluster 34) from hematopoiesis (Cluster 10) seen at the RNA level (Figure 
2.5) emerged independently with separation of their respective motif use. The most 
extensive code-sharing was centered on brain-specific Cluster 34, which radiates out 
shared motifs (shaded nodes) into numerous other clusters that contain genes expressed in 
both CNS and other tissues. A possible explanation for this CNS-centric pattern is that 
the involved TFs (and/or their paralogs) were recruited into new networks during 
evolution to support neuronal diversity. Finally, the ubiquitous-expression cluster 
produced by far the strongest motif enrichments in the entire transcriptome, mostly 
caused by ETS family motifs (Figure 2.48B and Figure 2.49D). ETS motif enrichment 
and occupancy has been associated previously with human housekeeping genes151, along 
with several other factors whose motifs are also enriched here, though to lesser extent 
(e.g. ZFX and CRE). 
To understand how ETS proteins are correlated with ubiquitous gene expression levels, I 
filtered out low abundance and high variance genes and divided the rest into three groups 
(high, medium, and low) by their abundances (Figure 2.49A). Surprisingly, these three 




(Figure 2.49D). It is possible that ETS proteins are only involved in activating or 
maintaining the ubiquitous expression pattern but do not fine-tune the absolute levels of 
each gene. In fact, when compared against GRO-seq data of C2C12 cells quantified in a 
similar way, these three groups of ubiquitous genes no longer have obvious differences in 
transcription rate (Figure 2.49B) compared to their mRNA abundances (Figure 2.49A). 
Notably, mRNA abundances of these genes are negatively related to their 3’ UTR length 
(Figure 2.49C). It is likely that transcripts with longer 3’ UTRs naturally harbor more 
binding sites for RNA degradation apparatus, such as RNAi pathway components and 
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Figure 2.49: Comparison between three groups of ubiquitous genes. Poly-A RNA-seq 
measurements of skeletal muscle (A), C2C12 GRO-seq data (B), and average 3’UTR 
length (C), are compared among three groups defined by their abundance measured by 
RNA-seq in the cumulative distribution function plots. (D) Significance of ETS motif 








Figure 2.50: Validation of 3’ UTR-mediated post-transcriptional regulatory 
mechanism in multiple samples. (A) Comparisons of 3’UTR length, GRO-seq, Bru-seq, 
and polyA RNA-seq assays among multiple different samples. Correlation scores 
between each pair of measurements on the columns and rows are visualized as a heatmap. 
In the corresponding cell of the comparison, a scatter plot is provided for the pair in 
comparison. On the diagonal, lined up are histograms of each individual measurement. 
(B) A model is proposed that longer 3’UTR may harbor more binding sites for RNA-
decay apparatus, leading to lower abundance at steady states. 
To test reproducibility of this phenomenon, I included more samples of RNA-seq, GRO-
seq152,153, and even Bru-seq154 for comparison. mRNA abundances of ubiquitous genes 
are more consistent across different samples than compared to transcription rate 
measurements (GRO-seq and Bru-seq) and are always negatively associated with 3’ UTR 
lengths, which are independent of transcription rate measurements (Figure 2.50A). These 
observations indicate that although transcription factors may set the ubiquitously 
expressed patterns of these groups of genes, the steady-state level of mature messenger 
RNAs are fine-tuned by their 3’ UTR-associated post-transcriptional regulation and slight 
modulation of transcription rate, independently. 
Another way to explore regulatory mechanisms for differential genes is to integrate 
histone mark distribution over differential gene clusters. Therefore, I processed histone 
mark ChIP-seq data from ENCODE155 and calculated their average enrichment over the 
promoters of the 34 differential gene clusters. This analysis checked average signal 
profiles of 8 different histone marks (H3K4me1, H3K4me2, H3K4me3, H3K9ac, 
H3K9me3, H3K27ac1, H3K27me3, and H3K36me3) in 12 tissues at up to 7 stages 
(E10.5 was removed due to inconsistent ChIP-seq protocol) against the promoters of all 




strong decreasing trend of H3K27me3, a well-known repressive chromatin mark, 
which anti-correlates with the up-regulated levels of RNA in the CNS-specific cluster, 
namely, Cluster 34 (Figure 2.41). This strong anticorrelation (decrease in H3K27me3 
signal and increase in RNA abundance) is not seen in other tissues with other gene 
clusters (Figure 2.51A and E), such as liver (Figure 2.51D), despite their similar RNA 
trajectories. I previously saw that the DNA binding motif for REST156/NRSF157, a known 
zinc-finger repressor of neuronal genes that decreases in brains (Figure 2.51C), is highly 
enriched in Cluster 34 (Figure 2.48B). It is likely that REST binds and represses the 
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Figure 2.51: CNS-specific genes are associated with Rest binding and de-repression. 
(A) H3K27me3 fold-decrease and RNA fold-change. Each bar represents a cluster of 
genes in a tissue type. The height represents RNA increase fold between the earliest and 
latest time points, while the colors represent H3K27me3 ChIP signal fold decrease. The 
arrows point to the strongest decrease of H3K27me3 that happens in Cluster 34 in brain 
samples. (B) NRSF target enrichment in individual clusters. Corrected P values are 
calculated based on Hypergeometric tests. (C) Abundance of NRSF mRNA in forebrain. 
(D-F) Averaged H3K27me3 profiles near promoter regions for liver ChIP-seq signals 
over Cluster 10 genes (D), forebrain ChIP-seq signals over Cluster 34 genes (E), and 
forebrain ChIP-seq signals over REST-targeted genes in Cluster 34 (F). 
Indeed, from ChIP-seq data in another study158, Cluster 34 is much more significantly 
enriched with REST-occupied genes than other clusters (Figure 2.51B). Analysis of 
REST/NRSF-occupied promoters showed even greater early-time H3K27me3 signal 
(Figure 2.51F). This in vivo brain result contrasts with an embryonic stem cell study in 
which no H3K27me3 enrichment was found at REST locations159 , but agrees with a 
culture-based neural progenitor study160. Although the genes in Cluster 34 that are not 
direct REST targets might be indirectly regulated by REST, it is possible that other 
repressors also play an important role in regulating CNS-specific genes. Additional 
repressive contributions might be mediated by other downward repressors such as Snai2, 
whose expression pattern is highly similar to Rest (they sit in the same clade of three 
genes in Cluster 16), possibly through a tandem negative feed-forward mechanism 
mediated by Mir124a161,162,163,164. 
2.3 Discussions 
The mouse fetal poly-A RNA matrix captured themes of histogenesis at multiple levels of 
organization. At the whole-embryo level, universal temporal RNA signatures were 




shifting proportions of constituent cell lineages, with each lineage maturing at its own 
pace toward cytodifferentiation. Although using whole-tissue embryo data alone cannot 
directly deconvolute cell type and lineage contributions to the whole-tissue 
transcriptome, I was still able to parse the transcriptome by comparing and contrasting 
expression profiles of different tissues at a wide range of stages assayed by the same 
protocol. My analyses separated transcriptome into ubiquitous and differential parts, the 
latter of which was further annotated into 34 major co-expression clusters. These 34 
clusters not only showed consistent ontology themes but also demonstrated interesting 
promoter regulatory codes. Ubiquitous genes possess coherent promoter codes, but post-
transcriptional regulation seems to secondarily modulate mRNA levels. Finally, 
integrating chromatin ChIP-seq data with cluster annotation highlighted a unique de-
repression mechanism of CNS-specific genes that are possibly mediated by the repressor 
REST/NRSF.  
Based on transcription “output” measurements, this whole-tissue RNA-seq study uses a 
divide-and-conquer strategy to parse the transcriptome and to further gain insights on 
their regulation, guiding follow-up experiments for deeper understanding of the genome. 
Although this study tries to make the most of the whole-tissue resource and to indirectly 




populations with weak saliency or low abundance. In the following chapter, I am going 
to discuss my single-cell study of tissue development. 
2.4 Materials and methods 
2.4.1 Whole-tissue RNA-Seq from mouse embryo tissues 
Pulverized pooled mouse embryo tissue replicates from timepoints E10.5, E11.5, E12.5, 
E13.5 E15.5, and E16.5 were received from the Ren lab which supplied these tissues for 
the entire mouse development project155. E14.5 and P0 tissues were dissected from single 
animals at Caltech. Replicate tissue samples were lysed and extracted using the Ambion 
mirVana protocol (AM1560). Residual genomic DNA was removed using the Ambion 
Turbo DNA-free kit (AM1907). Total RNA was quantified with Qubit, and RIN values 
were collected with the BioAnalyzer Pico RNA kit (5067-1513). The median RIN value 
was 9.7 (CV=4.4%). Each cDNA library was built using 10 ng total RNA spiked with 
ERCC spikes (AM4456740) diluted 1:5,000 in UltraPure H2O (InVitrogen 10977023) 
containing carrier tRNA (AM7119) at 100 ng/uL, RNAse inhibitor (Clontech 2313A) at 1 
units/uL and DTT (Promega P1171) at 1mM. cDNA was reverse transcribed and 
amplified according to the protocol in the SMARTer UltraLow RNA kit for Illumina 
(634935) using Clontech SMARTScribe reverse transcriptase (639536), and TSO, dT 
priming, and amplification primers from the Smart-seq2 protocol30 . The first strand 
product was cleaned up on Ampure XP beads, and then amplified using the Clontech 
Advantage 2 PCR kit (639207) with 13 PCR cycles and an extension time of 12 minutes. 
After a second round of Ampure XP cleanup, the amplified cDNA was quantified on 




4626). cDNA libraries were then tagmented using the Illumina/Nextera DNA prep kit 
(FC 121-1030) with index tags from Illumina (FC 121-1031), cleaned up with Ampure 
XP beads, quantified on Qubit, and sized with the Agilent HS DNA kit. Libraries were 
sequenced on the Illumina HiSeq 2500 as 100 bp single-end reads to 30M aligned reads 
depth. Inclusion for ENCODE submission required replicate concordance scores by 
Spearman correlation of FPKM values > 0.9. 
2.4.2 Reads mapping and quantification 
All the whole-tissue RNA-seq data were processed through the standard ENCODE 
pipeline (https://www.encodeproject.org/pipelines/ENCPL002LSE/).Downstream 
analyses were mainly done using MATLAB scripts 
(https://github.com/brianpenghe/MATLAB-genomics).  
 
2.4.3 Whole-Tissue RNA-seq quality control, PCA, CCA, and Hierarchical 
clustering 
tRNA genes and genes covered by fewer than 10 reads in all tissues were removed. PCA 
was performed over the log2-transformed FPKM values with 0.1 added as pseudo-counts. 
CCA was performed on the top 20 PCs’ and Boolean variables for tissue identities, 
thymus contamination, gender identities and stages (17 + 1 + 2 + 8 variables). Dynamic 
genes were defined as those with at least 10-fold difference (otherwise defined as flat, or 
ubiquitous) in FPKM values between the most and least abundant RNA samples. 
Dynamic genes and ubiquitous genes are further categorized into different classes based 
on gene types (protein-coding, lincRNA, etc.) annotated by GENCODE M4. One-way 




average linkage. Clusters were defined by traversing from the root of the tree towards 
the leaves and splitting out clades with different tissue dominance and GO terms, 
recognized manually, until no more major clusters could be split out. Clades with at least 
30 nodes were defined as major clusters. 
2.4.4 Motif analysis 
The analysis of transcription factor recognition motifs was carried out using version 
4.11.2 of the MEME-SUITE165. Motifs annotated in the CIS-BP database4 
(http://cisbp.ccbr.utoronto.ca/) were used to evaluate motif enrichment around the TSSs 
(500bp stream) of each cluster of similarly expressed genes; enrichment was scored by 
the AME program in the MEME-SUITE165. The analysis was carried out twice based on 
UCSC mm10 refFlat and GENCODE M4 separately, and only motifs with corrected p-
values smaller than 0.01 in both analyses were called significant.  
2.4.5 Ubiquitous gene analysis 
Among the genes defined ubiquitous by the whole-tissue RNA-seq analysis, those with 
log2(FPKM+0.1) values no higher than 2 were removed. The 3000 genes with smallest 
sample variance were equally assigned into high, medium, and low groups based on their 
average FPKM values.  
GRO-seq and Bru-seq reads were mapped and quantified using the ENCODE standard 




extracted from GENCODE M4 annotation. The log2(FPKM+0.1) values and log10(3’ 
UTR length) were used for comparisons.  
2.4.6 Histone modification analysis 
Histone modification ChIP-seq data were processed using the ENCODE ChIP-seq 
pipeline (https://www.encodeproject.org/pipelines/ENCPL220NBH/) and Log2 fold 
change for ChIP-seq samples over input controls were calculated and plotted using 
Deeptools2.4.1166 (https://github.com/fidelram/deepTools/tree/2.4.1). To summarize fold 
decrease of histone modification signals in a specific sample among a specific cluster of 
genes, a 4kb window enclosing TSS at the center was used and average log2 fold change 
against input samples were calculated. The fold decrease was the difference between the 
fold changes of the earliest and latest timepoint. Rest target overlap p value was 
calculated based on hypergeometric test using iQNP Rest ChIP-seq target list158. 
 
2.4.7 Gene Ontology Analysis 
FuncAssociate167 3.0 (http://llama.mshri.on.ca/funcassociate/ ) was used at its default 




C h a p t e r  3  
SINGLE-CELL TRANSCRIPTOMIC STUDY OF EMBRYONIC FORELIMB 
Abstract 
Mammalian tissue development is a complex process coordinating dynamic changes in 
multiple cell lineages. These cell lineages differ in their own ways of differentiation, 
migration, and turnover pace. To understand mechanisms of these processes, I present 
here a single-cell transcriptomic study of mouse embryonic forelimb from E10.5 to 
beyond E13.5. Based on the most variable features of the transcriptome, major cell 
lineages were identified and tracked, whose differential transcription factor networks 
highlighted both gradual and Boolean transitions between stages. My result presents the 
first high-resolution transcriptome atlas of the developing forelimb and provides new 
insights in regulation of cell state transition in limb development. 
3.1 Introduction 
The mouse forelimb is a classic model to study tissue development. It is composed of 
multiple cell lineages including muscle, skin, skeletal, endothelial, and immune lineages. 
Its rich existing knowledge base and ease to dissect make it an ideal tissue to perform 
modern high-throughput high-dimensional transcriptom measurements. Single-cell 
transcriptome data can identify constituent cell-types and states that comprise a complex 
tissue168,21,169,170. For embryogenesis, scRNA-seq further promises to address long-
standing questions about the number of transcription states that comprise a given 




data offer a critical input for gene network modeling by unambiguously assigning to an 
individual cell (or defined cell group) its transcription factor repertoire and candidate 
downstream target genes. Major contemporary methods of scRNA-seq have 
complementary strengths for these purposes, with some assaying modest numbers of cells 
at relatively high transcript detection efficiency and RNA isoform coverage, while others 
capture larger cell numbers at lower transcript detection efficiency and without isoform 
or promoter use information81. I present an analysis of ENCODE single-cell RNA-seq 
resource of the former type for the developing limb. These data identified and parsed 
major known limb cell lineages and stages within them, revealed how relative 
contributions change over developmental time, and enabled inference of corresponding 
differential TF networks. 
3.2 Results 
3.2.1 Resident and immigrating cell types identified 
The whole-tissue transcriptome analysis implied three biological themes of histogenesis 
that could be further illuminated by high quality single cell data: 1) cell lineage 
specification and progression to differentiation, 2) immigration of new cell types, and 3) 
differential proliferation and/or cell death between cell types (Figure 3.1). To capture 
their transcriptome signatures and assemble underlying regulatory networks, our lab 
produced 920 high-quality single-cell transcriptome profiles distributed from E10.5 to 
E15 beyond (Figure 3.3A). Fluidigm C1 single-cell platform was chosen to maximize 
compatibility with whole-tissue data by using the same RNA-seq biochemistry, 




detection (Figure 3.2B and C) and coverage. In aggregate, we detected 17,987 protein 
coding and 1562 lincRNAs, of which 98% and 90% respectively overlap with the limb 
whole-tissue RNA-seq time-course (Figure 3.2). 
 
Figure 3.1: Three principles underlying dynamic regulation of gene expressions in whole 
tissues. Tissues at earlier stages are the circles on the left while later ones are on the right. 
Smaller shapes represent cells and those in the same color belong to the same type.  
To separate putative cell types, I selected the top 1500 high dispersion (variance divided 
by mean of log2-transformed FPKM values) genes and only kept protein-coding genes 
coded in the nucleus (rather than the mitochondrium). Two-way clustering of these 1269 
remaining genes across all cells (Figure 3.3B) identified 11 cell types of different origins: 
the chondrogenic/osteogenic lineages and the resident limb mesenchyme from which they 
arise, the independently immigrating myogenic, monocyte/macrophage, endothelial, and 
neural crest lineages. Only a few epithelial cells were sampled due to our intentional 
removal during tissue dissection (see 3.4 Materials and Methods). Cell identity 




marker genes (Figure 3.4F) of each lineage. In addition to these marker genes, genes 
involved in proximal-distal patterning of the limb (Hox genes), cell-cycle regulation 
(such as Ccnb1), and cell signaling (such as Pdgfa and Pdgfra) were also found to be 
heterogeneously expressed in the forelimb. 
 
 
Figure 3.2 Quality metrics of whole-tissue RNA-seq and single-cell RNA-seq. (A) 
Numbers of protein-coding genes and lincRNAs detected in ENCODE whole limb RNA-
seq and single-cell forelimb RNA-seq data. (B) Average single molecule capture 
probability (psmc) in single-cell limb experiments. (C) Quantification of spike-in 
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controls. The heatmap shows the RNA-seq FPKM values of spike-in transcripts. Each 
row represents a spike-in transcript and each column represents one cell. Superimposed 
on the heatmap is a cumulative curve (magenta) of detection rate for each spike-in 
transcript. 50% and 90% detection rates are highlighted by white vertical bars on the plot. 
On the right are the expected number of copies of transcripts of the spike-in controls 
matching the rows on the left panel.  
Multiple replicates confirmed the reproducibility of cell type classifications (Figure 
3.3B). Additionally, an initial 10x Genomics platform was used to do 3’-transcript 
counting assays. Around 50,000 cells were sequenced, and the result was very similar 
(Figure 3.4A). 
 
Figure 3.3 Single cell analysis reveals multiple subpopulations bearing distinct gene 
signatures. (A) Limb development schematic. Arrow indicates immigrating lineages that 
enter the resident limb bud mesenchyme. (B) Hierarchical clustering of single-cells 
(horizontal axis) and genes (vertical) performed based on the highest dispersion genes 
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colors representing time points using the same color code applied in (D). (C) Cell type 
composition is plotted as a time series with time as x-axis and percentages as y-axis. The 
color code corresponds to highlighted cell clusters in (B) and gives provisional cell 
identity (see text). (D) Individual cells are laid out on 2D t-SNE planes, with the 
embryonic stages of tissue origin (left) and cell cluster membership color-coded from 
(B). (E) Monocle lineage inference. (F) Normalized log-transformed expression levels of 
selected genes are visualized as heatmaps on the t-SNE plane. 
The only differences are probably the additional clusters seen in 10X data. An additional 
muscle cell cluster with exclusive Myot expression was split out from the Muscle 3 
cluster (Figure 3.4B) that was not clearly seen in C1 data, probably due to under-
sampling of late time points after e14 in C1 experiments. Indeed 4 cells in C1 collection 
showed Myot expression but ended up in Muscle 3 cluster probably due to low cell 
number. Epithelial cell type splitted into two clusters in 10X data while equivalent cells 
in C1 dataset only formed one cluster. A possible explanation is that the ectoderm could 
not be well removed at later stages and that under-sampling of it in C1 experiments made 
it hard to identify. Even so, the epithelial cluster of C1 data still contains both 
subpopulations. Finally, red blood cells formed a new cluster on 10X t-SNE plot. Gene 
signatures of these cells were only seen in 4 cells in C1 data labeled as different cell 
types. This means that C1 experiments could not perfectly isolate and capture red blood 
cells unless they stuck to other cells. Cell size and shape might have been the underlying 






Figure 3.4 3’-transcript tagging method reveals discrete cell types. (A) Individual cells 
visualized on 2D t-SNE planes. Colors represent cell types. (B) Counts of Myot 
transcripts. Normalized log-transformed Myot counts are visualized using the color 
scheme on the right. Cell coordinates on the 2D t-SNE plane are the same as (A). 
3.2.2 Developmental lineage progression and gradients of cell-signature salience 
Using algorithms such as t-SNE (Figure 3.3D) and Monocle 2 (Figure 3.3E), major 
developmental trajectories of the limb are highlighted. Early stage samples (E10.5-11.5) 
are dominated by resident limb mesenchymal cells and early muscle precursors (eMPC) 
(Mesenchyme1 and Muscle1 cell clusters); while at later timepoints, immature 
chondrocytes, perichondrial cells, myoblasts (MB), and early myocytes (eMC) (Muscle 2 
and Muscle 3 cell clusters, respectively) emerge (Figure 3.3C). After E14.5, perichondrial 
cells dominate the chondrogenic/osteogenic lineage while myocytes increasingly 
represent the myogenic lineage (Figure 4C and 3D), although they are likely under-










































represented because they fuse into large multinucleate myotubes that are not 
successfully recovered into the single cell format. 
Overall, the inferred lineage relationships were consistent with classical and genetic 
knockout and modern tracing studies. For example, early myogenic progenitors enter the 
limb bud from adjacent axial somites, requiring the TF Pax3 for cell migration171,172,173, 
and Pax3 emerged as the strongest differential gene defining the Muscle1 cell cluster 
(p=4.7e-12 by t-test). Together, Monocle and t-SNE defined a tri-partite myogenic 
progression (Figure 3.3D and 3.3E), whose subdivision was informed by 1) sharply 
cluster-restricted genes (Figure 3.6A) that split stages (e.g. regulators Pax3, Pax7, Msc, 
Myog) and by 2) pan-lineage and multi-cluster regulators that joined stages together (e.g. 
Pitx2/Pitx3, Myod1) (Fig. 3.6A and B). These results confirm at single-cell resolution the 
prior microarray results from FACS analysis of GFP targeted muscle precursor 
cells174,175. My model with respect to myogenesis shares some overall characteristics with 
one constructed for in vitro differentiation of human adult muscle85, but it differs 
substantially in the stages represented and in many pertinent regulators, reflecting both 
known and newly highlighted differences between adult in vitro and embryo in vivo 
systems. The EMP to macrophage relationship is also clearly evident in the data. 
Skeletogenesis is also prominent, comprising the largest lineage fraction. Condensation, 
ongoing expansion, and differentiation into cartilage and bone are the primary fate of the 
resident limb mesenchyme176,177. It is represented here in the global models that focus on 




partitioned and ordered than myogenesis. Substantially deeper cell sampling will 
likely be needed to develop strong lineage models. 
Although cell type and lineage classification can be done based on their most prominent 
and specific gene expression signatures, a spectrum of different salience was observed. In 
the limb system, cell-specific signatures increased in complexity as lineages progressed 
(Figure 3.5). More mature types (e.g. Muscle 3 or Macrophage) were easier to define and 
detect because their highly salient signatures discriminated both inter- and intra-lineage 
distinctions (Figure 3.5). However, early cell types and progenitors (Muscle1, EMP, and 
Mesenchyme1) displayed lower salience, with very few progenitor-unique genes 
compared to their more differentiated counterparts. Defining such progenitor types was 
bolstered by their early, and sometimes very low-level, expression of multi-stage and 
pan-lineage genes (Figure 3.5B). 
 
    
Figure 3.5 Cell-type relationships and salience. (A) Spearman coefficients between 
different single-cells. Spearman coefficients were calculated from high-dispersion genes 








and are visualized by a heatmap. Colored dendrograms from Figure 3.3B are used to 
label cell types. (B) Boolean markers (not expressed elsewhere) for single and combined 
cell type(s). Genes specifically enriched in one or selected combinations of multiple cell 
types are included. Normalized log-transformed FPKM values are visualized as 
heatmaps. 
3.2.3 Lineage networks integrate Boolean versus quantitative regulators 
Differentially expressed TF sets for each major cell type and stage were extracted and 
their known protein and genetic relations used to organize them into interaction networks 
(Figure 3.6A and C). In the myogenic lineage, some regulators show strong contrast 
between the cell cluster stages. Pax3 uniquely marked muscle precursor identity 
(Muscle1) (Figure 3.6B and F) and is replaced by Pax7 which is positive only in the 
intermediate myoblast-like cell state and then turns off (Figure 3.3F). Myog and Zbtb18 
are turned on late in differentiating myocytes (Muscle 3)(Figure 3.6B and F). In contrast 
to these stark Boolean regulators, more gradual quantitative regulators like Pitx3, Hes6, 
Myod1, and Ybx3 can be detected early in precursor cells and ramp up gradually through 
later stages, while Hmgb3 and Hmga1 are gradually reduced (Fig. 3.6A). Boolean-type 
TF switches were also found in the progression from the EMP state to the pre-




whereas Emr1 showed the opposite pattern, and Runx1 joined the two cell stages 
while discriminating them from others in the limb. 
 
Figure 3.6 Differentially expressed transcription factors. (A) Heatmap of expression 
levels of the differentially expressed transcription factors. Cell identities labeled on top 
match those in Figure 3.3B. (B) Distributions of expression levels in distinct muscle 
states. (C) STRING networks of three muscle states based on enriched differential 
transcription factors. 
The distinction between Boolean and quantitative regulators cannot be seen in a whole-
tissue time course because the average profiles of both Boolean and quantitative 
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actually do have different transition patterns. It is possible that downstream targets of 
quantitative regulators have intrinsic thresholds to translate quantitative regulator 
concentration into discrete ways of actions and thus lead to discrete cell fates. More work 
is demanded to better understand this already complex network since Boolean and 
quantitative factors do not act independently but actually interact with each other based 
on STRING database178 (Figure 3.6C). 
3.3 Discussions 
While the large-scale whole-tissue RNA-seq measures the average profile of mixed cell 
types that go through differentiation, migration, and unsynchronized turn-over, I 
demonstrated the power of single-cell RNA-seq analysis that directly decomposed much 
of this complexity by separating multiple cell lineages and stages for limb development, 
revealing distinct graded versus Boolean patterns of TF change along individual lineage 
axes. Lessons about complexity and salience of gene signatures at different 
developmental stages were also learned from this limb single-cell data, which can be 
useful for future experiment design and data interpretation.  
3.4 Materials and methods 
3.4.1 Single-cell transcriptome measurements using the Fluidigm C1 
One pair of embryonic forelimbs from a single mouse was used at each timepoint (E10.5, 
E11.5, E12.5, and E13.5). After dissection from the carcass, limbs were incubated in a 50 
uL droplet of a 10% collagenase solution (Worthington LS004202) for 5 minutes at 
37 ℃. The limbs were then visualized under a dissecting scope and the ectoderm was 




bud was then transferred to a 200 uL droplet of Accumax (AM105), and the dish was 
reincubated for 15 minutes at room temperature. The cells were then manually triturated 
once with a P200 tip to suspend them, and pipetted into 500 uLs of DMEM + 10% FBS. 
Limb cells were spun at 500g for 5 minutes at 4℃, resuspended in 500 uLs fresh DMEM 
+ 10% FBS, and passed over a 20 micron mesh (Miltenyi 130-101-812). They were then 
counted and diluted in DMEM + 10% FBS to achieve a final concentration of 250,000 
cells/mL. 12 uLs of this suspension was added to 8 uLs of Fluidigm Cell Suspension 
Reagent for loading on the Fluidigm IFC (10-17 micron size). Cells were then visually 
inventoried for doublets and empty chambers, and returned to the C1 for lysis, reverse 
transcription, and amplification using the SMART-Seq v4 protocol. Lysis buffer: 8.6 uLs 
water, 1 uLs C1 loading buffer, 2.4 uLs Smart-seq2 oligo(dT) primer (10mM), 2.4 uLs 
Clontech 10mM dNTPs, 2 uLs ERCC spikes (AM4456740) (diluted 1:40,000 in 
UltraPure H2O (InVitrogen 10977023) containing carrier tRNA (AM7119) at 200 pg/uL, 
RNAse inhibitor (Clontech 2313A) at 1 units/uL and DTT (Promega P1171) at 1mM), 
0.5 uLs 100mM DTT, 2.6 uLs Clontech single-cell reaction buffer. Reverse transcription 
reaction: 5.6 uLs Clontech 10X transcription buffer, 0.6 uLs C1 loading buffer, 5.6 uLs 
Smart-seq2 TSO (10mM), 0.4. uLs Clontech RNAse inhibitor, 2.8 uLs Clontech 
SMARTScribe. PCR reaction: 4.4 uLs water, 4.5 uLs C1 loading buffer, 75.2 uLs 
Clontech SeqAmp buffer, 3 uLs Smart-seq2 amplification primers (10 mM) and 2.9 uLs 
Clontech SeqAmp polymerase. 
Amplified cDNA samples were diluted in 10 uLs of C1 DNA dilution reagent, and a 1 uL 




BioAnalyzer sizing based on yield and chamber occupancy. An aliquot of the cDNA 
libraries was diluted to 0.1 – 0.3 ng/uL using C1 Harvest reagent, and the libraries were 
then tagmented using the Nextera XT DNA sample prep kit (FC 131-1096) and Nextera 
XT indices (FC 131-1002). After tagmentation and amplification, libraries were pooled, 
cleaned up twice with Ampure XP beads (0.9X volume), quantified on Qubit, and sized 
on the BioAnalyzer using the HS DNA kit. The libraries were sequenced as 50 bp single 
reads to a depth of about 1M aligned reads. 
3.4.2 Reads mapping and quantification 
Single-cell C1 RNA-seq data were processed through the standard ENCODE pipeline 
(https://www.encodeproject.org/pipelines/ENCPL002LSE/). Single-cell 10X data were 
processed by Cell Ranger (https://support.10xgenomics.com/single-cell-gene-
expression/software/pipelines/latest/what-is-cell-ranger). Downstream analyses were 
mainly done using MATLAB scripts (https://github.com/brianpenghe/MATLAB-
genomics).  
3.4.3 Cell-type and lineage-specific marker genes identification. 
To identify cell types, 1500 genes with highest dispersion (variance over mean) of log-
transformed FPKM values were selected, and only nuclear protein-coding genes were 
kept. Then these cells were hierarchically clustered using Spearman correlation. Cell 
clusters were then manually picked based on enriched genes. Marker genes were defined 
as those that were significantly enriched against background cell type (Mesenchyme 2) 
based on one-tailed t-test (p < 0.00001) using log-transformed FPKM values. Genes with 




removed due to low effect size. I did this analysis for each of the cell type other than 
the background cell type and for combinations of related cell types (Muscle 1+Muscle 2, 
Muscle 2+Muscle 3, Muscle1-3, Chondrocyte+Perichondrium, EMP+Macrophage). 
Mesenchyme 2 markers were defined to be those with more than 3 fold enrichment 




C h a p t e r  4  
INTEGRATING ENCODE WHOLE-TISSUE DATA AND SINGLE-CELL RNA 
PROFILES 
Abstract 
The mammalian genome undergoes robust regulation during development in a cell type-
specific manner. Here I present analyses combining single-cell information with 
ENCODE whole-tissue measurements to gain insights on cell type-specific gene 
signatures and regulatory architecture. Single-cell measurements captured a lot of 
features that whole-tissue measurements could not discover even with large-scale 
combinatorics. Whole-tissue data combined with single-cell RNA-seq also parsed 
chromatin signatures contributed by high-salience cell types and provided valuable maps 
of candidate cis-regulatory elements. This chapter demonstrates the broader use of single-
cell data for deeper mining of regulatory mechanisms. 
4.1 Introduction 
The mammalian genome undergoes robust regulation during development. Numerous 
high-throughput biochemical assays have been developed in the past decade to 
characterize the input and output of the dynamic genome, most of which are limited to 
whole-tissue level without single-cell resolution. One exception is RNA-seq, which has 
been advanced to robust high-throughput and automated fashions with single-cell 
resolution and has been widely used and understood in recent years. To comment on the 




tissue RNA-seq methods, and to leverage the ENCODE resources, I am providing 
integrative analyses of single-cell RNA-seq data and ENCODE whole-tissue data. 
  
4.2 Results 
4.2.1 Single-cell limb signatures parse whole-tissue limb cell compositions 
 
Since the whole-tissue RNA-seq data in Chapter 2 and single-cell RNA-seq C1 data in 
Chapter 3 were both generated using protocols based on SMART-seq210, a direct 
comparison between them would be reasonable. Due to the fact that ENCODE limb 
samples contain both the forelimb and hindlimb and do not match our single-cell data 
which were derived only from forelimb, our lab also built whole-forelimb RNA-seq data 
to assess the difference. 
Using the high-dispersion nuclear protein-coding genes derived in Chapter 3 as an input, 
CIBERSORT179, a method for estimating cell composition of complex tissues, was able 
to infer the fraction of each known cell type in the mixed-cell tissues (Figure 4.1). In 
Chapter 3, I talked about the fact that late-stage muscle cells might be under-represented 
in single-cell data because they tend to fuse into large multinucleate myotubes that are 






    
Figure 4.1 Cell composition of limb tissues inferred by CIBERSORT. (A) Forelimb 
whole-tissue cell composition inferred from single-cell signatures. X-axis denotes 
development stages while the height along Y-axis represents percentage of cells for 
certain cell types. (B) Cell composition of ENCODE mixed limb tissues inferred from 
single-cell signatures visualized in a similar way to (A). 
That might partially explain the drop in empirical fraction of myoblast and myocyte 
(Figure 3.3C). However, based on CIBERSORT estimation, even in whole-tissue data 
myoblast and myocyte also drop after E13.5 (Figure 4.1). This implies that the decrease 
fraction of mature cell types in late-stage forelimb tissue may not be an artifact of single-
cell isolation protocol but is probably due to differential turn-over rate between lineages. 
Muscle lineage propagation may not catch up with the rapid production of cell types in 
other lineages, such as perichondrial cells from mesenchyme differentiation. Therefore, 
the relative abundance of muscles cells gradually decreases, although the absolute 
quantity is probably increasing as the forelimb grows bigger. 
Based on CIBERSORT’s estimation, the single-cell dataset has roughly the same 






















































good sampling of major types of cells. The only discrepancy lies in minor cell type 
identification, especially those with weak gene signature salience (Muscle 1 and EMP 
cells). Those cell types do not have enough exclusive marker genes (Figure 3.5B) for 
recognition of their presence and have only a small number of samples (cells).  
Furthermore, I performed a similar analysis for ENCODE mixed limb RNA-seq data. 
Overall, mixed forelimbs and hindlimbs did not show a dramatically different 
composition. Major differences include a higher percentage of “Epithelial” and 
“Mesenchyme 1” cells at late stages for ENCODE mixed dissections, partially due to 
their different dissection method. 
 
Overall, using independent single-cell data, the cell composition of a tissue can be 
estimated from its whole-tissue RNA profile. But it has to be kept in mind that, although 
transcripts from individual cells are always extracted and processed together for whole-
tissue assays, which assumes that a linear average of them are finally sampled in the 
whole-tissue RNA-seq library, the library construction process amplifies them with 
exponential noise, random dropout, and other types of biases, making it hard to robustly 
infer cell composition, especially for low-salience cell types. 
4.2.2 Local versus global identities 
 
Although limb tissue has a unique structure and function compared to other parts of the 
body, its cell types as building blocks are mostly also seen in other tissues. This implies 




collected, by comparing them to each other, it might be possible to identify a lot of 
cell type-signatures as minimal modules. That has been the goal of the study in Chapter 
2. Indeed multiple modules were identified. These modules contain genes with similar 
expression patterns, corresponding to collinearity patterns in the high dimensional space, 
which can thus be transformed by PCA to capture major features (principal components). 
To understand whether the single-cell limb gene signatures were already identified in the 
whole-tissue data, I mapped the marker genes of each cell type onto the differential 
cluster map of whole-tissue data, and plotted the distribution of their coordinates on the 
map as violin plots (Figure 4.2). Marker genes of EMP and macrophage cells mainly 
concentrate on Cluster 10, which features hematopoiesis. Although these cells have a low 
fraction in the limb tissue, they have a large number of prominent markers and broad 
distribution across multiple tissues. Therefore, whole-tissue RNA-seq data already 
identified Cluster 10 to represent this signature. Similarly but less prominent, Muscle 3 
signature overlaps with Cluster 2 (skeletal muscle) and Cluster 3 (cardiac muscle) 
featuring myogenesis, while the perichondrial signature overlaps with Cluster 16 
featuring the extracellular matrix. Interestingly, this analysis also captured the fact that 
Mesenchyme 1, Muscle 1, and EMP cells as progenitor cell types have a slight overlap 
with Cluster 21 which represents cell cycle regulation, consistent with their active 
proliferating feature. However, none of the low-salience cell types had their cell type-
exclusive signature discovered by the whole-tissue cluster analysis. Their marker genes 
are usually dispersed across multiple clusters due to the fact of the multi-tasking nature of 




features in other tissues and thus get assigned to different places. An independent 
CCA was also performed to look for linear combinations of whole-tissue profiles that can 





Figure 4.2 Cell type-specific markers mapped onto the bulk clustergram. Cell type-
specific markers mapped onto whole-tissue clustergram. Each cell type has its markers 
positioned at corresponding y-axis position on the right, aligned with genes in the whole-
tissue clustergram on the left. The distributions of these positions are smoothed into 
violin plots for better visualization. 
These analyses show that single-cell RNA-seq has irreplaceable power to find features of 
certain cell populations that cannot be recognized by whole-tissue measurements, due to 
representation and salience issues. It also showed that defining a “marker gene” or a 
multi-gene cell-type signature is inevitably context dependent. Context ambiguity also 
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affected cell-type markers first defined elsewhere. For example, fate mapping studies 
have shown that some early mesenchyme, including a subset of Myf5 expressing cells, 
become fat rather than muscle180, but expression of a prominent brown fat discriminator 
from that study (Prdm16) was widespread across all cell types in the developing limb 
context (data not shown). 
4.2.3 scRNA-seq data deconvolve candidate cis-regulatory elements by cell type 
 
The ENCODE histone mark, chromatin accessibility, and DNA methylation data provide 
rich biochemical signatures from which candidate cis-acting regulatory elements (cCRE) 
have been computationally inferred at the whole-tissue level181,182. However, the resulting 
cCREs are, for each tissue, an unresolved admixture of chromatin from all cell types of 
the tissue. To begin to parse cis-elements by cell type, as illustrated by the diagram in 
Figure 4.3, I merged limb DNase hypersensitive sites (DHSs) from ENCODE as 
candidate regulatory elements, associated each of them with the nearest promoter of an 
expressed gene, and then integrated them with a whole-tissue epigenomic regulatory state 
model181,182 (IDEAS, see Methods) to identify active elements. Finally, the active 
elements that associate with cell type or lineage-specific marker genes were extracted. 
Overall, I was able to assign 4631 candidate active and poised elements to individual 
limb cell types and lineages. It was encouraging that DHS and chromatin marks from 
whole limb tissue had the sensitivity to identify known validated enhancers specific for 
cell clusters comprising less than 10% of the starting tissue (notably Muscle 3 and 
Macrophage, Figure 4.4A and C). Previously validated cCREs were affiliated with these 




385 (95%) had at least one affiliated active or poised element (median 6 elements per 
gene), and all limb lineages and clusters had detectable elements. Modeling cell-
type/state-preferential cCRE in this way should now be possible for any ENCODE matrix 
tissue with the addition of its corresponding sc-RNA data and its integration with IDEAS 
or other epigenomic state models. 
 
 
Figure 4.3 Assigning candidate cis-regulatory elements to cell types. Three types of data 
on the left are used to derive the final model of cell-type cCREs on the right. Arrows 
















































































































































































































Figure 4.4 Representative cell type-specific cis-regulatory elements. (A) 
Computationally predicted limb myocyte cCREs. Active or bivalent cCREs are labeled 
with horizontal black bars on top, the cell-type specific (exclusive) ones of which are 
labeled in purple below. IDEAS states are shown below the cCREs bars. Red represents 
active promoters. Orange represents active distal enhancers. Blue and purple represent 
inactive regions. Mixed colors represent intermediate states. Bulk DNase and RNA-seq 
data tracks as well aggregated single-cell RNA-seq data tracks are shown at the bottom. 
An image of enhancer assay result of an element overlapping Mu3 is shown on the right, 
taken from a published paper by Yee et al183. (B) Skeletal enhancers (Ca1-3) shown with 
in vivo enhancer validation from the VISTA resource for Ca3 
(https://enhancer.lbl.gov/frnt_page_n.shtml) at the Sox5 locus. (C) The C1qb locus that is 
macrophage-specific. Three cCREs (Lb1-3) for limb-specific expression of this 
macrophage gene were identified. The contrasting promoter proximal element (Lv1) is 
active in liver and has a corresponding DHS profile.  
4.3 Discussions 
Whole-tissue biochemical measurements present a high degree of complexity that arises 
from shifting cell composition and unsynchronized maturation pace. Single-cell RNA-seq 
proved to be able to not only separate cell type-specific gene signatures that whole-tissue 
data could not identify, but also assess the composition of known cell types in whole-
tissue data. This latter power will be even more profound when the cell atlas of individual 
tissues are complete. Before single-cell epigenomic assays are ready for reliable and wide 
use, single-cell RNA-seq measurements could be integrated with whole-tissue 
measurements to infer the most prominent cell type-specific and lineage-specific 
regulatory codes. My analyses demonstrate how a simple integration algorithm can infer 
regulatory mechanisms at cell-type level and show the power of single-cell RNA-seq 




4.4 Materials and methods 
4.4.1 Bulk forelimb RNA-Seq from mouse embryo tissues 
Forelimbs were individually dissected and processed using exactly the same protocol as 
in 2.4.1. 
4.4.2 Comparing whole-tissue RNA-seq and single-cell RNA-seq. 
Filtered top 1500 high-dispersion nuclear protein coding genes (See 3.4.3) were used as 
input for CIBERSORT179 to compare against whole limb RNA-seq data. To compare 
marker genes defined from 3.4.3 against ENCODE whole-tissue RNA-seq clusters, 
marker genes defined for each cell type were matched to the ordered heatmap of the 
whole-tissue clustergram (Figure 2.5A). For better visualization, I not only showed 
individual locations as horizontal bars but also borrowed violin plots to show smoothed 
distribution of these marker genes. 
4.4.3 IDEAS states 
The IDEAS epigenetic states on the ENCODE3 mouse developmental data were 
generated by the IDEAS software181,182 using 10 epigenetic marks: H3K27ac, 
H3K27me3, H3K36me3, H3K4me1, H3K4me2, H3K4me3, H3K9ac, H3K9me3, ATAC-
Seq, and DNAse methylation data. We first converted the raw data in each sample to –
log10 p-values using a Negative Binomial model. The mean and variance parameters of 
the model for each sample were calculated using the bottom 99% of the data. We then 
adjusted the mean parameters at each genomic position from the input data to account for 
local genomic variations. Specifically, we downloaded the input data for each tissue (see 
list of data sets), and we calculated rolling means per genomic position using a 20kb 
window centered at the position, for both signals and the input. The ratio between the two 




normalized the ratios across the genome to have mean 1. We treated the –log10 p-
value as input data for IDEAS, capped at 16, and we ran the program in its default 
setting. The output from IDEAS is a set of genome tracks to display in the genome 
browser, where each epigenetic state is assigned a color as a weighted mixture of colors 
pre-assigned by the program to each epigenetic mark. The IDEAS segmentation can be 
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